Podcasts about clinical psychiatry

Hey friends,I'm giving a talk tonight at a beach party

Professor David Taylor is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at KCL. David is the Editor-in-Chief of the journal Therapeutic Advances in Psychopharmacology. Professor Taylor has been the lead author of the Maudsley Prescribing Guidelines since their inception in 1993. David has also authored over 375 clinical papers in journals such as the Lancet, BMJ, JAMA Psychiatry, British Journal of Psychiatry and Journal of Clinical Psychiatry. Today we discuss: - What the science says about the effectiveness of anti-depressants.- Evidence based principles for prescribing anti-depressants safely. - Common side effects and withdrawal symptoms. - Do anti-depressants work via so called "emotional numbing" effects?- The use of anti-depressants for other conditions such as OCD and PTSD. - Emerging treatments for depression such as ketamine and psilocybin. - New treatments for psychosis such as KarXT (Cobenfy). Interviewed by Dr. Alex Curmi. Dr. Alex is a consultant psychiatrist and a UKCP registered psychotherapist in-training.If you would like to invite Alex to speak at your organisation please email alexcurmitherapy@gmail.com with "Speaking Enquiry" in the subject line.Alex is not currently taking on new psychotherapy clients, if you are interested in working with Alex for focused behaviour change coaching , you can email - alexcurmitherapy@gmail.com with "Coaching" in the subject line.Give feedback here - thinkingmindpodcast@gmail.com - Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast Tiktok - @thinking.mind.podcast 

In recognition of National Eating Disorder Awareness Week, we're revisiting an important episode focused on disordered eating. Angelique Serrano speaks with Dr. Evelyn Attia, Director of the Center for Eating Disorders at NewYork-Presbyterian. They discuss the differences between healthy and unhealthy eating, how to recognize the signs of eating disorders, and what treatment options are available today. Dr. Attia offers guidelines for people of all ages who want to have a healthy relationship with food.___Dr. Evelyn Attia is Director of the Center for Eating Disorders at New York-Presbyterian, an integrated clinical research program at both Weill Cornell Medicine and Columbia University Medical Centers. Dr. Attia is a Professor of Clinical Psychiatry at Weill Cornell Medicine and Clinical Professor of Psychiatry at Columbia University College of Physicians & Surgeons. Formerly the director of the inpatient eating disorders program at The New York State Psychiatric Institute, Dr.  Attia has more recently focused on research involving the psychobiology and treatment of anorexia nervosa. Since 1999, she has received uninterrupted funding for her research from the National Institute of Mental Health (NIMH). Dr. Attia is a member of the eating disorders work-group for DSM-5. She is also a member of The Eating Disorders Research Society and has been elected Fellow of the Academy for Eating Disorders. (source)___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org

On today's episode of Get Psyched, we're excited to welcome Dr. Joseph Cooper, Associate Professor of Clinical Psychiatry at the University of Illinois, Chicago. Dr. Cooper directs residency training and the Behavioral Neurology and Neuropsychiatry Fellowship and serves as co-chair of the National Neuroscience Curriculum Initiative (NNCI). Dedicated to integrating neuroscience into psychiatric education, he plays a key role in shaping curricula and making neuroscience more accessible for mental health professionals. Join us as Dr. Cooper breaks down neuropsychiatry, explaining where it overlaps with psychiatry and neurology. We'll also explore what neuropsychiatry training entails, the essential role of neuroscience in understanding brain-behavior relationships, and how this field is transforming psychiatric care.

Hey Team! Today, I'm talking with Dr. Ryan Sultan, a distinguished psychiatrist specializing in ADHD, anxiety, depression, and substance use disorders. He serves as an Assistant Professor of Clinical Psychiatry at Columbia University Irving Medical Center and the New York State Psychiatric Institute. And he has also been exploring the evolutionary basis for ADHD. Now, let's get to a few things up front here because often when I hear about evolution and ADHD, I know I'm about to hear something about ADHD as a superpower. That's not what this conversation is about today. While we will be looking at how ADHD traits might have been useful in a pre-industrial world and why natural selection didn't weed out our distractible, impulsive brains, the focus is more on how those brains thrived within society instead of looking at them in isolation. This means that our conversation mostly focuses on how these ADHD traits work in conjunction within society rather than trying to view them either negatively or positively. And then we also get into how understanding this evolutionary basis for ADHD can help us understand better ways of managing and treating ADHD. If you'd life to follow along on the show notes page you can find that at HackingYourADHD.com/211 Subscibe to our YouTube channel here Support us on Patreon This Episode's Top Tips Regarding the evolutionary basis of ADHD, avoid thinking of it in terms of better or worse and instead try to see how ADHD traits can serve the community as a whole. With that lens in mind, the impulsivity, novelty-seeking, and hyper-focus of ADHD brains could have been advantages in early human societies, especially for hunting, exploring, and problem-solving in unpredictable environments. With the opposite from the structured, repetitive, sit-still-and-focus world we live in today giving us more difficulties because it wasn't “designed” with the ADHD brain in mind. Neurodiversity can benefit everyone. Societies thrive on diverse thinking styles. ADHD brains bring creativity, spontaneity, and out-of-the-box problem-solving, which can be a huge asset when properly supported. We're better when we work together.

Deugen mensen van nature? Psychologie professor Philip Zimbardo is onlangs overleden en deed onderzoek naar alles rondom dit onderwerp. Bekend van het Stanford Prison Experiment, wat behoorlijk onder vuur is komen te liggen, ook door Rutger Bregman die met zijn boek De Meeste Mensen Deugen probeerde aan te tonen dat Zimbardo het mis had. Maar is dat wel echt zo? Deugen mensen echt? Of in sommige omstandigheden juist niet? Duik mee in al deze thematiek met Thijs Launspach en Lennard Toma! Bronnen en ander lees- en luister- en kijkvoer: - Philip Zimbardo lees je over op z'n wiki pagina: https://en.wikipedia.org/wiki/Philip_Zimbardo - Check Meeste Mensen Deugen van Rutger Bregman - Stanford Prison Experiment kun je genoeg info over vinden, zoals deze van VSauce: https://www.youtube.com/watch?v=KND_bBDE8RQ - VSauce ook met Zimbardo over hoe je van iemand een held kunt maken: https://www.youtube.com/watch?v=JMpuxLIgjPs - Luister naar onze oude podcast over de Dark Triad: https://open.spotify.com/episode/7l5Rvfvcgp9v8ytdKp4vI6?si=85f5f13578cf4ddd Nerd-literatuur: - Franco, Z. & Zimbardo, P. (2006–2007) [The banality of heroism](http://greatergood.berkeley.edu/article/item/the_banality_of_heroism) [Archived](https://web.archive.org/web/20120618102406/http://greatergood.berkeley.edu/article/item/the_banality_of_heroism) June 18, 2012, at the [Wayback Machine](https://en.wikipedia.org/wiki/Wayback_Machine). Greater Good, 3 (2), 30–35 - Franco, Z. E.; Allison, S. T.; Kinsella, E. L.; Kohen, A.; Langdon, M.; Zimbardo, P.G. (2018). "Heroism research: A review of theories, methods, challenges, and trends". Journal of humanistic psychology. *58* (4): 382–396. - Franco, Z.E.; Zimbardo, P.G. (2016). Miller, A.G. (ed.). "The psychology of heroism: Extraordinary champions of humanity in an unforgiving world" in The Social Psychology of Good and Evil. New York: Guilford Press. pp. pp. 494-523. [ISBN](https://en.wikipedia.org/wiki/ISBN_(identifier)) [9781462525409](https://en.wikipedia.org/wiki/Special:BookSources/9781462525409). - Franco, Z. E., Blau, K., & Zimbardo, P. G. (2011). Heroism: A conceptual analysis and differentiation between heroic action and altruism. Review of general psychology, 15(2), 99-113. - Bocchiaro, P.; Zimbardo, P.G.; Van Lange, P.A. (2012). "To defy or not to defy: An experimental study of the dynamics of disobedience and whistleblowing". Social Influence. *7* (1): 35–50. - Bocchiaro, P.; Zimbardo, P.G. (2010). "Defying unjust authority: An exploratory study". Current Psychology: A Journal for Diverse Perspectives on Diverse Psychological Issues. *29* (2): 155–170. - Fischer, P., Greitemeyer, T., Pollozek, F., & Frey, D. (2006). The unresponsive bystander: Are bystanders more responsive in dangerous emergencies?. European journal of social psychology, 36(2), 267-278. - Grevet, E. H., Bandeira, C. E., Vitola, E. S., de Araujo Tavares, M. E., Breda, V., Zeni, G., ... & Bau, C. H. D. (2024). The course of attention-deficit/hyperactivity disorder through midlife. European Archives of Psychiatry and Clinical Neuroscience, 274 (1), 59-70. - Sibley, M. H., Kennedy, T. M., Swanson, J. M., Arnold, L. E., Jensen, P. S., Hechtman, L. T., ... & Hinshaw, S. P. (2024). Characteristics and Predictors of Fluctuating Attention-Deficit/Hyperactivity Disorder in the Multimodal Treatment of ADHD (MTA) Study. The Journal of Clinical Psychiatry, 85(4), 57313.

In this episode, we talk with Dr. William Breitbart, Chairman of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center, and a pioneer in psycho-oncology. Dr. Breitbart sheds light on the critical yet often overlooked issue of meaning and purpose in cancer care. He delves into how patients may encounter a profound loss of meaning, which can lead to anxiety and depression, even if they are not clinically diagnosed with depression. Drawing from his extensive experience, Dr. Breitbart shares insights from his pioneering work in the psychiatric and neuropsychiatric dimensions of cancer and palliative care. He discusses strategies to assist patients in rediscovering meaning and enhancing their quality of life during challenging times. Join us for a conversation that underscores the vital intersection of mental health and cancer treatment, featuring Dr. Breitbart's significant contributions to the field, including his groundbreaking work on Meaning-Centered Psychotherapy. William Breitbart, M.D. Chairman, Jimmie C Holland Chair in Psychiatric Oncology; Chairman, Department of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center Dr. Breitbart is a pioneer and leader in the field of psycho-oncology. At Memorial Sloan-Kettering Cancer Center, he led the way for innovative, award-winning initiatives that provided high-quality research focusing on psychiatric and neuropsychiatric aspects of cancer and palliative care. He is the Chairman, Jimmie C Holland Chair in Psychiatric Oncology, Chairman, Psychiatry Service, Department of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York. Dr. Breitbart is also a Professor of Clinical Psychiatry at Weill Medical College of Cornell University. Dr. Breitbart is known for numerous influential leadership roles, and has been recognized in the field of psycho-oncology for his contributions, receiving top research awards and lifetime achievements since 2003. He has edited/written twelve textbooks, including Psychiatric Aspects of Symptom Management in the Cancer Patient, published by the American Psychiatric Press, Psycho-oncology - 1st, 2nd and 3rd Editions, and Handbook of Psychiatry in Palliative Medicine- 1st and 2nd Editions. Dr. Breitbart recently authored treatment manuals on Meaning-Centered Group and Individual Psychotherapy in Advanced Cancer Patients by Oxford University Press. He is currently editor-in-chief of the Cambridge University Press' international palliative care journal, Palliative & Supportive Care. Dr. Breitbart also helped found IPOS Press and authored the IPOS Press/Oxford University Press Text Psychosocial Palliative Care. --- Support this podcast: https://podcasters.spotify.com/pod/show/aimatmelanoma/support

Tommy checks in with Dr. Michelle Moore, Associate Professor of Clinical Psychiatry at LSU Health New Orleans and serves as Section Chief for Psychology

Attention Deficit Hyperactivity Disorder or ADHD is often perceived as a static diagnosis– one that people carry with them throughout their lives with little to no change. But, new research may just change that view of ADHD all together. A recent study in the Journal of Clinical Psychiatry suggests that ADHD symptoms can actually fluctuate over time due to influence from environmental factors. In fact, for many individuals, symptoms can mellow out year after year - especially for people who are navigating a busy life.  Guest: Maggie Sibley, a clinical psychologist and Professor of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine, and Seattle Children's Hospital. She's also the lead author of the new study. Relevant Links: Characteristics and Predictors of Fluctuating Attention-Deficit/Hyperactivity Disorder in the Multimodal Treatment of ADHD (MTA) Study - The Journal of Clinical Psychiatry See omnystudio.com/listener for privacy information.

Clinical Psychiatry professor and practitioner Dr. Camilo Ortiz joins me to speak about his research into child anxiety and hard stand against "gentle parenting." Follow: https://x.com/DrCamiloOrtiz Learn more! https://letgrow.orgSupport this channel:  https://www.paypal.me/benjaminboycehttps://cash.app/$benjaminaboycehttps://www.buymeacoffee.com/benjaminaboyce --- Support this podcast: https://podcasters.spotify.com/pod/show/calmversations/support

This conversation discusses the development of the Certificate of Postgraduate Training in Clinical Psychiatry (the Certificate), funded by the Australian Government. The Certificate is designed for medical practitioners in Australia (PGY5+) who want to learn foundational concepts in psychiatry and develop practical clinical skills to assess and support patients who present with mental health conditions. The program includes four core areas with an elective that can be related to your interests. It offers flexibility and experiential learning, allowing participants to continue working in their primary places of work -while under clinical supervision by experienced psychiatrists.Chair of the Expert Advisory Group, Dr Bill Kingswell, and members of the Expert Advisory Group and Curriculum Authorship Steering Group, Dr Matthew Ruhl and Dr Catherine Andronis, discuss why medical practitioners should enrol into the Certificate and the benefits of undertaking the program for general practitioners and rural generalists.Dr Bill Kingswell is a psychiatrist with a long-term interest in the educational activities of the RANZCP and chaired the Expert Advisory Group which governed this project.Dr Matthew Ruhl is a rural generalist (FACRRM), with an advanced skill in mental health and special interests in addiction and sexual health, and all facets of LGBTIQAPSB+ health. He has worked for the past decade in hospitals and health facilities across south-east Queensland. Matt is an active clinical educator for the Australian College of Rural and Remote Medicine (ACRRM) and continues to study actively, is a novice researcher and supports medical student and doctor education. In his spare time, he enjoys his artistic pursuits as an amateur stained-glass maker, cooking, gaming, and sleep (especially sleep!). Dr Catherine Andronis is a Melbourne-based GP with a special interest in mental health, and a family therapist.  She is currently the Chair of the Royal Australian College of General Practitioners (RACGP) Psychological Medicine Specific Interests group, as well as a medical educator and a keen advocate for mental health care in Australia.Topic suggestion:If you have a topic suggestion or would like to participate in a future episode of Psych Matters, we'd love to hear from you.Please contact us by email at: psychmatters.feedback@ranzcp.orgDisclaimer:This podcast is provided to you for information purposes only and to provide a broad public understanding of various mental health topics. The podcast may represent the views of the author and not necessarily the views of The Royal Australian and New Zealand College of Psychiatrists ('RANZCP'). The podcast is not to be relied upon as medical advice, or as a substitute for medical advice, does not establish a doctor-patient relationship and should not be a substitute for individual clinical judgement. By accessing The RANZCP's podcasts you also agree to the full terms and conditions of the RANZCP's Website. Expert mental health information and finding a psychiatrist in Australia or New Zealand is available on the RANZCP's Your Health In Mind Website.

Most clinicians know that depression, anxiety and other mood disorders are treatable conditions. Unfortunately, clinicians often face barriers when accessing care for themselves. To better understand why, we welcome Dr. Karen Swartz, Professor of Clinical Psychiatry at Johns Hopkins to … Ep. 6 — “I should be able to manage this myself”:  The unique challenges of getting clinicians to access mental health care | Johns Hopkins Medicine Office of Well-Being Read More »

What drives a person to commit mass murder? With such a heinous crime, it's difficult to understand the motivations and mental illnesses that exist within a person's mind which lead them to carry out violence on a devastating level. However, research can help explain the existing patterns to better understand the factors at hand and prevent these crimes from happening in the future. Professor of Clinical Psychiatry at the Columbia University Department of Psychiatry and New York State Psychiatric Institute Dr. Ragy Girgis is the curator of the Columbia Mass Murder Database. He provides a glimpse into his research and discusses how we can prevent mass murders today. Follow Emily on Instagram: @realemilycompagno If you have a story or topic we should feature on the FOX True Crime Podcast, send us an email at: truecrimepodcast@fox.com Learn more about your ad choices. Visit megaphone.fm/adchoices

In this interview for MIA Radio, Brooke Siem speaks with David Taylor and Mark Horowitz about their publication of the Maudsley Deprescribing Guidelines, which is of particular note since the Maudsley Prescribing Guidelines is a leading text in medicine worldwide. David Taylor is the Director of Pharmacy and Pathology at Maudsley Hospital and a Professor of Psychopharmacology at King's College in London. He is also the editor-in-chief of the journal Therapeutic Advances in Psychopharmacology. Beyond academia, he contributes significantly to public health policy as a member of the United Kingdom's Department of Transport expert panel that introduced drug-driving regulations. He is also a current member of the UK government's Advisory Council on the Misuse of Drugs and is the only pharmacist to have been made an honorary fellow of the Royal College of Psychiatrists. David is the lead author of the Maudsley Prescribing Guidelines, a role he has held since their inception in 1993. The Maudsley Prescribing Guidelines have achieved significant success, with over 300,000 copies sold across 14 editions and translations into 12 languages. David has also authored 450 clinical papers published in prominent journals such as The Lancet, BMJ, British Journal of Psychiatry, and Journal of Clinical Psychiatry. His work has been cited over 25,000 times. Mark Horowitz is a clinical research fellow in psychiatry at the National Health Service (NHS) in London. He is a Visiting Lecturer in Psychopharmacology at King's College London and an Honorary Clinical Research Fellow at University College London, in addition to being a trainee psychiatrist. Mark holds a PhD from the Institute of Psychiatry, Psychology, and Neuroscience at King's College London, specializing in the neurobiology of depression and antidepressant action. He is the lead author of the Maudsley Deprescribing Guidelines and an associate editor of Therapeutic Advances in Psychopharmacology. Mark co-authored the recent Royal College of Psychiatry's guidance on stopping antidepressants, and his work has informed the recent NICE guidelines on the safe tapering of psychiatric medications, including antidepressants, benzodiazepines, and z-drugs. He has collaborated with the NHS to develop national guidance for safe deprescribing for clinicians and has been commissioned by Health Education England to prepare a teaching module on how to safely stop antidepressants. Mark has published several papers on safe approaches to tapering psychiatric medications, with contributions in The Lancet Psychiatry, JAMA Psychiatry, and Schizophrenia Bulletin. His interest lies in rational psychopharmacology and the deprescribing of psychiatric medications, which is deeply informed by his personal experiences of the challenges associated with coming off psychiatric medications. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2024. Produced by James Moore https://www.jmaudio.org

Join Dr. Andy Cutler as he talks with the co-author of the winning poster from the 2023 NEI Congress Young Investigator Poster Competition, Dr. Richard Price. They discuss the objectives, design, and key findings of the poster titled, “Improved Mood and Weight Gain Mitigation Following Switch from Aripiprazole to Cariprazine.” They also discuss the potential implications of these findings and applications of cariprazine in psychiatry.  Dr. Richard Price is an Assistant Professor of Clinical Psychiatry at Weill Cornell Medical College. Maxwell Zachary Price, the lead author of the winning poster, is a medical student at Hackensack Meridian School of Medicine.  See the winning poster here.    Learn about upcoming NEI Meetings at https://nei.global/meetings  

We'd love to hear from you about this episode.Mental health is a topic that we hear about often. Managing the mental dimension of wellness is essential at every stage of life, from childhood and adolescence through adulthood.It is estimated that nearly 20 million of our nation's young people can currently be diagnosed with a mental health disorder. The U.S. Department of Health and Human Services stated that 1 in 5 U.S. children (ages 3–17) has a mental, emotional, behavioral, or developmental disorder. Many more are at risk of developing a disorder due to biological, family, school, ecological, political, peer, and community risk factors. Our relationship with the natural world is critical in supporting good mental health and preventing mental and emotional distress.Welcome to Episode Forty-Four of The Nature of Wellness Podcast.  In this episode, we sat down with Dr. Matthew Biel, Chief of the Division of Child and Adolescent Psychiatry at MedStar Georgetown University Hospital and a Professor of Clinical Psychiatry and Pediatrics at Georgetown University School of Medicine. Join us as we speak to Matt about how he interacts with the natural world, how time in nature can be a powerful mental health service,  and how one's environment plays a vital role in developing and maintaining a child's mental well-being. Matt discusses the impact of adversity and stress on children and families, the importance of reducing health disparities,  and ways to improve access to mental health services.  This conversation was just what the doctor ordered…literally.Please subscribe, rate, and leave a review anywhere you listen to this podcast.We appreciate you all. Be Well-NOWDr. Biel Linkedin:https://www.linkedin.com/in/matthew-biel-ab97163/Georgetown University Center for Trauma and the Community:https://ctc.georgetown.edu/Youtube-Child Psychiatry: Ask Dr. Matthew Biel:https://www.youtube.com/watch?v=ifUr2Pmh7_4Dr. Biel Publications:https://www.researchgate.net/profile/Matthew-Biel* The unbelievable Shawn Bell produces the Nature of Wellness Podcast, making us sound good.** The NOW theme song was penned, performed, produced, and provided by the dynamic duo of Phil and Niall Monahan. *** This show wouldn't exist without our amazing guests and all of you who listen. Please like, subscribe, follow, and review to help us get these important messages out to more folks who can benefit from them. Thank you all.

Welcome to the Social-Engineer Podcast: The Doctor Is In Series – where we will discuss understandings and developments in the field of psychology.   In today's episode, Chris and Abbie are discussing Overworking. They will talk about the causes, symptoms and what you can do to combat it. [May 6, 2024]   00:00 - Intro 00:17 - Dr. Abbie Maroño Intro 00:47 - Intro Links -          Social-Engineer.com - http://www.social-engineer.com/ -          Managed Voice Phishing - https://www.social-engineer.com/services/vishing-service/ -          Managed Email Phishing - https://www.social-engineer.com/services/se-phishing-service/ -          Adversarial Simulations - https://www.social-engineer.com/services/social-engineering-penetration-test/ -          Social-Engineer channel on SLACK - https://social-engineering-hq.slack.com/ssb -          CLUTCH - http://www.pro-rock.com/ -          innocentlivesfoundation.org - http://www.innocentlivesfoundation.org/                                 04:37 - The Topic of the Day: Overworking 05:17 - Working vs Overworking 06:35 - Telltale Signs 08:47 - Keep Balanced 10:35 - Apples and Oranges 15:08 - Time for a Rest 19:52 - Do the Right Thing 21:49 - The Illusion of Control 24:58 - Bury the Bad 27:11 - Accountability of Emotions 28:58 - Lack of Boundaries 30:12 - Communication is Key! 35:58 - Tides are Turning 36:58 - Wrap Up 37:15 - Next Month: Internal Motivation 37:33 - Outro                                                                     -          www.social-engineer.com -          www.innocentlivesfoundation.org   Find us online: -          Twitter: @DrAbbieofficial -          LinkedIn: linkedin.com/in/dr-abbie-maroño-phd -          Instagram: @DoctorAbbieofficial -          Twitter: @humanhacker -          LinkedIn: linkedin.com/in/christopherhadnagy     References: Chandola, T., Brunner, E., & Marmot, M. (2010). Chronic stress at work and the metabolic syndrome: Prospective study. BMJ, 332(7540), 521-525. https://doi.org/10.1136/bmj.38693.435301.80 Cohen, S., Janicki-Deverts, D., & Miller, G. E. (2012). Psychological stress and disease. Journal of the American Medical Association, 298(14), 1685-1687. https://doi.org/10.1001/jama.298.14.1685 Kivimäki, M., Jokela, M., Nyberg, S. T., Singh-Manoux, A., Fransson, E. I., Alfredsson, L., ... & Theorell, T. (2015). Long working hours and risk of coronary heart disease and stroke: A systematic review and meta-analysis of published and unpublished data for 603,838 individuals. The Lancet, 386(10005), 1739-1746. https://doi.org/10.1016/S0140-6736(15)60295-1 Maslach, C., & Leiter, M. P. (2016). Understanding the burnout experience: Recent research and its implications for psychiatry. The American Journal of Psychiatry, 173(6), 1235-1241. https://doi.org/10.1176/appi.ajp.2016.15040416 Nakata, A. (2011). Work hours, sleep sufficiency, and prevalence of depression among full-time employees: A community-based cross-sectional study. Journal of Clinical Psychiatry, 72(5), 605-614. https://doi.org/10.4088/JCP.10m06447gry Palmer, K. T., Harris, E. C., Coggon, D. (2007). Chronic musculoskeletal pain in working populations: Where there is smoke, there is work to be done. Occupational and Environmental Medicine, 64(4), 219-220. https://doi.org/10.1136/oem.2006.031252 Schaufeli, W. B., & Bakker, A. B. (2004). Job demands, job resources, and their relationship with burnout and engagement: A multi-sample study. Journal of Organizational Behavior, 25(3), 293-315. Sonnentag, S. (2012). Psychological detachment from work during leisure time: The benefits of mentally disengaging from work. Current Directions in Psychological Science, 21(2), 114-118. Virtanen, M., Ferrie, J. E., Singh-Manoux, A., Shipley, M. J., Stansfeld, S. A., Marmot, M. G., ... & Kivimäki, M. (2011). Long working hours and symptoms of anxiety and depression: A 5-year follow-up of the Whitehall II study. Psychological Medicine, 41(12), 2485-2494. https://doi.org/10.1017/S0033291711000171 Young, K. S. (2017). The relationship between depression, anxiety, and smartphone addiction among university students. Journal of Behavioral Addictions, 6(3), 434-445.

The cannabis available today is much, much stronger than the weed grandma was smoking back in her day and the effects on our brains are much more significant than previously thought. Really, no really!  Jason and Peter sought out Dr. Ryan Sultan an Assistant Professor of Clinical Psychiatry at Columbia University to understand the underlying reasons for our growing inability to get along but when we had him in studio we also picked his brain relating to his expertise in cannabis. He's also an expert in the areas of anxiety, mood disorders, depression, ADHD, and substance abuse. Ryan graciously agreed to help us understand why Peter has been so edgy lately since he's gone cold turkey off marijuana. IN THIS EPISODE: Peter isn't alone in having a hard time coming off pot. Lung cancer, stroke, anxiety, a shrinking brain? The new huge study on long-term cannabis use. The effects of long term cannabis consumption. What happens to your brain when you stop regular use of pot. Cannabis, rebound anxiety + ADHD. The reason kids should stay away from pot until at least age 25. *** FOLLOW DR. SULTAN He is the director of Integrative Psych, as well as being director of Sultan Lab at Columbia University. Instagram @rsultanmd X @DrRyanSultan *** FOLLOW REALLY NO REALLY: www.reallynoreally.com Instagram YouTube TikTok Facebook Threads XSee omnystudio.com/listener for privacy information.

It's becoming impossible to ignore the epidemic of public incivility. Tirades in supermarkets, performers pelted with projectiles, drunken movie goers brawling, tantrums on airplanes, and of course, the Oscar slap seen around the world! This can't all just be coincidence. Social media constantly churns out evidence of this growing trend which begs the question: Which came first, the incivility or the smartphone cameras capturing it all? Really, no really? Jason and Peter sought out an expert in human behavior to help discover the underlying reasons for our growing inability to get along. And Dr. Ryan Sultan an Assistant Professor of Clinical Psychiatry at Columbia University graciously agreed to help us understand society's current decline in decency. IN THIS EPISODE: What is “Main Character Syndrome” and is it real? Performers who've spectacularly called out disrespectful audience members. How COVID affected people's temperament and children's ability to mature and develop. How our reality has been impacted by smart phones, social media, and curated feeds. Anger, happiness and the algorithms that feed us. The restorative power of interpersonal relationships - can they be replicated online? Airplane tantrums, toxic Yelp reviews, prolific road rage, are there common threads instigating these behaviors? Is the “Karen phenomenon” new or are we just catching it on camera more? Broadway memories – How Jason dealt with onstage outbursts. Google-heim: Stemming the tide of incivility using the 4 Agreements. *** FOLLOW DR. SULTAN He is the director of Integrative Psych, as well as being director of Sultan Lab at Columbia University. Instagram @rsultanmd X @DrRyanSultan *** FOLLOW REALLY NO REALLY: www.reallynoreally.com Instagram YouTube TikTok Facebook Threads XSee omnystudio.com/listener for privacy information.

Cafer's Psychopharmacology| Dr Jason Cafer is an assistant Professor of Clinical Psychiatry at University of Missouri-Columbia. He is certified by the American Board of Psychiatry and Neurology and also the American Board of Preventive Medicine. In 2007 he founded Iconic Health, a medical informatics startup that obtained angel round funding. He was Principal Investigator for Phase I and II Small Business Innovation Research (SBIR) grants for "Online Rural Telepsychiatry Platform" that was funded by the United States Department of Agriculture. He is the inventor of United States Patent which was the subject of an SBIR grant awarded by the Department of Health and Human Services for "Medication IconoGraphs: Visualization of Complex Medication Regimens". Visit his website to learn more about Cafers' Psychopharmacology. https://www.cafermed.com/blog Behnaz Sarrami, MS, PharmD  Becky Winslow, PharmD  Dr. Jason Cafer, MD  

Navigating the intricate landscape of mental health can often feel like deciphering a complex puzzle, especially when differentiating between conditions ADHD vs.anxiety. This challenge is further compounded by the similarities in symptoms and the potential for misdiagnosis. However, understanding the nuances and interconnections between these conditions can empower individuals to seek appropriate treatment and improve their quality of life. ADHD, or Attention Deficit Hyperactivity Disorder, is a neurodevelopmental condition characterized by symptoms of inattention, hyperactivity, and impulsivity. While commonly diagnosed in childhood, ADHD persists into adulthood for many individuals, affecting various aspects of their daily lives, from academic performance to personal relationships. On the other hand, anxiety disorders encompass a range of conditions marked by excessive fear, worry, and physical symptoms such as heart palpitations and dizziness. The intersection of ADHD and anxiety is a topic of significant interest within the mental health community. Individuals with ADHD often experience anxiety, partly due to the challenges and frustrations stemming from ADHD symptoms. Similarly, the constant struggle with focus and organization can exacerbate feelings of anxiety, creating a cyclical relationship between the two conditions. A critical aspect of differentiating ADHD from anxiety involves examining the onset and progression of symptoms. ADHD is present from an early age, with symptoms often becoming noticeable during childhood. In contrast, anxiety can develop at any point in life, triggered by stressors or traumatic events. Therefore, a thorough evaluation of an individual's history is vital in distinguishing between the two. Moreover, the manifestation of symptoms can offer clues. For example, while both ADHD and anxiety can lead to concentration difficulties, the underlying reasons differ. In ADHD, the inability to focus is often due to intrinsic attention regulation issues. In anxiety, however, the concentration problems may arise from excessive worry or fear that consumes cognitive resources. Understanding the unique and overlapping aspects of ADHD and anxiety is crucial for effective treatment. For ADHD, interventions typically include medication, such as stimulants, alongside behavioral strategies to enhance executive functioning skills. Anxiety disorders, meanwhile, may be treated with a combination of psychotherapy, such as cognitive-behavioral therapy (CBT), and, in some cases, medication to manage symptoms. The integration of treatment modalities is paramount, particularly for individuals experiencing both ADHD and anxiety. Addressing the ADHD symptoms can often alleviate anxiety by improving self-esteem and coping mechanisms. Similarly, managing anxiety can reduce the overall stress load, making ADHD symptoms more manageable. In conclusion, ADHD and anxiety represent two distinct yet interrelated conditions within the spectrum of mental health. The complexity of their relationship underscores the importance of personalized, comprehensive treatment plans. By fostering a deeper understanding of these conditions, individuals can navigate the path to wellness with greater clarity and confidence. This journey, though challenging, is a testament to the resilience and strength inherent in the human spirit, as we seek to understand and overcome the obstacles that lie within our minds. TRANSCRIPT Kimberley: Welcome, everybody. We are talking about ADHD vs anxiety, how to tell the difference, kind of get you in the know of what is what.  Today, we have Dr. Ryan Sultan. He is an Assistant Professor of Clinical Psychiatry at Columbia University. He knows all the things about ADHD and cannabis use, does a lot of research in this area, and I want to get the tea on all things ADHD and anxiety so that we can work it out. So many of you listening have either been misdiagnosed or totally feel like they don't really understand the difference. And so, let's talk about it. Welcome, Dr. Sultan. ADHD vs. ANXIETY  Ryan: Thank you. I really like doing these things. I think it's fun. I think psychiatrists, which is what I am, I think one of the ways that we really fail, and medical doctors in general don't do well at this, which is like, let's spend some time educating the public. And before my current position, I did epidemiology and public health. And so, I learned a lot about that, and I was like, “You know how you can help people? We have a crisis here. Let's just teach people things about how to find resources and what they can do on their own.” And so, I really enjoy these opportunities.  WHAT IS ADHD vs. WHAT IS ANXIETY?   I was thinking about your question, and I was thinking how we might want to talk about this idea of ADHD versus anxiety, which is a common thing. People come in, and they see me very commonly wanting an evaluation, and they think they have ADHD. And I understand why they think they have ADHD, but their main thing is basically reporting a concentration or focus issue, which is a not specific symptom. Just like if I'm moody today, that doesn't mean I have a mood disorder. If I'm anxious today, it doesn't mean I have an anxiety disorder. I might even feel depressed today; it doesn't mean I have a depression disorder. I could even have a psychotic symptom in your voice, and it does not mean that I have a psychotic disorder. It's more complicated than that.   I think one of the things that the DSM that we love here in the United States—but it's the best thing we have; it's like capitalism and democracy; it's like the best things that we have; we don't have better solutions yet—is that it describes these things in a way that uses plain language to try to standardize it. But it's confusing to the general public and I think it's also confusing to clinicians when you're trying to learn some of these conditions.  WHEN IS ADHD vs. ANXIETY DIAGNOSED?  And certainly, one of the things that have happened in my field that people used to talk a lot about is the idea that, is pediatric, meaning kid diagnosis of ADHD, which often in my area here in the United States will be done by pediatrician, are they adequately able to do that? Because poor pediatricians have to know a lot. And ADHD, psychiatric disorders are complicated. Mental health conditions are super complicated. They're so complicated that there are seven different types of degree programs that end up helping you with them. PsyD, PhD, MD, clinical social worker, mental health counselor, and then there's nurse practitioner. So, like super complicated counseling. So, how do we think about this?  The first thing I try to remind everyone is, if you're not sure what's going on with you, please filter your self-diagnosis. You can think about it, that's great. Write your notes down, da-da-da, but I would avoid acting purely on that. You really want to do your best to get some help from the outside. And I know that mental health treatment is not accessible to everyone. This is an enormous problem that existed before the pandemic and still exists now. I say that because I say that all the time, and I wish I had a solution for you. But if you have access to someone that you think can help you tease this throughout, you want to do that.  SYMPTOMS OF ADHD vs. ANXIETY  But what I would like us to do, instead of listing criteria, which you can all Google on WebMD, let's think about them in a larger context. So, mental health symptoms fall into these very broad categories. And so, some of them are anxiety, which OCD used to be under, but it's now in its own area. Another one, would be mood. You can have moods that are really high, moods that are really low. Another one you could take ADHD, you could lump it in neurodevelopmental, which would mix it with autism and learning disorders. You could lump it with attention, but the problem with that is it would also get lumped with dementia, which are processes that overlap, but they're occurring at different ends of the spectrum.   So, let's think about ADHD and why someone might have ADHD or why you might think someone has ADHD, because this should be easier for people to tease out, I think. ADHD is not a condition that appears in adulthood. That's like hands down. Adult ADHD is people that had ADHD and still have ADHD as adults. And most people with ADHD will go on to still have at least an attenuated version, meaning their symptoms are a little less severe, maybe, but over 60% will still meet criteria. It's not a disorder of children. Up until the ‘90s, we thought it was a disorder of kids only. So, you turned 18, and magically, you couldn't have ADHD anymore, which didn't make any sense anyway.   So, to really get a good ADHD diagnosis, you got to go backwards. If you're not currently an eight-year-old, you have to think a little bit about or talk to your family, or look at your school records. And ideally, that's what you want to do, is you want to see, is there evidence that you have, things that look like ADHD then? So, you were having trouble maintaining your attention for periods of time. Your attention was scattered in different ways. Things that are mentally challenging that require you to force yourself to do it, that particularly if you don't like them, this was really hard for you. You were disorganized. People thought that things went in one year and out the other.   Now this exists on a spectrum. And depending on the difficulty of your scholastic experience and how far you pushed yourself in school, these symptoms could show up at different times. For example, it's not uncommon for people to show up in college or in graduate school. Less so now, but historically, people were getting diagnosed as late as that, because now they have to write a dissertation. For those of you guys who don't know, a dissertation is being asked to write a book, okay? You're being asked to write a book. And what did you do? You went to college. Okay, you went to college, and then you had some master's classes, and then you get assigned an advisor, and you just get told to figure out what your project is. It is completely unstructured. It is completely self-sufficient. It is absurd. I'm talking about a real academic classic PhD. That is going to bring it. If somebody has ADHD, that's going to bring it out because of the executive functioning involved in that, the organization, the planning. I got to make an outline, I got to meet with my mentor regularly, I got to check in with them, I got to revise it, I got to plan a study or a literature review. There's so many steps involved. So, that would be something that some people doesn't come up with then.   Other kids, as an eight-year-old boy that I'm treating right now, who has a wonderful family that is super supportive, and they have created this beautiful environment for him that accommodates him so much that he has not needed any medication despite the fact that there's lots of evidence that he is struggling and now starting to feel bad about himself, and he has self-esteem issues because he just doesn't understand why he has to try so hard and why he can't maintain his attention in this scenario, which is challenging for him.   So, ADHD kids and adults, you want to think of them as their brains as being three to five years behind everyone else in their development, okay? And they are catching up, but they're more immature, and they're immature in certain ways. And so, this kid's ability to maintain his attention, manage his own behaviors, stay organized, it's like mom is sitting with this kid doing his homework with him continuously, and if she stops at all, he can't hold it together on his own. So, when we think about that with him, like, okay, well, that's maybe when it's showing up with him. That's when it's starting to have a struggle with him.   But let's relate it to anxiety. One problem would be, do you have ADHD or do you have anxiety? Well, there's another problem. Another problem is having ADHD is a major risk factor for developing an anxiety disorder, okay? So now I'm the eight-year-old boy, and this eight-year-old boy does not have the financial resources to get this evaluation, or the parents that are knowledgeable enough to know that, it might even have been years ago where there was less knowledge about this. And he's just struggling all the time, and he feels bad about himself, and he's constantly getting into trouble because he is losing things because he can't keep track of things because he's overwhelmed. And now he feels bad about himself. Okay. He has anxiety associated with that. So now we're building this anxiety. So he might even get mood symptoms, and now we have a risk for depression.   So, this is just one of the reasons why these things are like these tangled messes. You ever like have a bunch of cords that you have one of the dealies, you keep throwing them in a box, and now you're like, “What do I do? Do I just throw the cords out or entangle them?” It's a very tangled mess. Of course, it takes time to sort through it. The reason I started with ADHD is that it has a clear trajectory of it when it happens. And in general, it's a general rule, symptomatology, meaning like how severe it is and the number of symptoms you have and how impairing it is. They're going to be decreasing as you get older. At least until main adulthood, there's new evidence that shows there might be a higher risk for dementia in that population.   But let's put geriatric aside. There's a different developmental trajectory. Whereas anxiety, oh God, I wish I could simplify anxiety that much. Anxiety can happen in different ways. So, let's start with the easy thing. Why would you confuse them in this current moment? If I am always worried about things, if I'm always ruminating about things, I'm thinking about it over and over again, I'm trying to figure out where I should live or what I should do about this, and I just keep thinking about it over and over again, and I'm in like a cycle. Like, pop-pa-pa pop-pa pop-pa-pa-pa. And then you're asking me to do other things. I promise you, I will have difficulty concentrating. I promise you, I can't concentrate because it's like you're using your computer and how many windows do you have open? How many things are you running? I mean, it doesn't happen as much anymore, but I think most of us, I meant to remember times where you're like, “Oh, my computer is not able to handle this anymore.” You're using up some of your mind, and you can call that being present.   So, when people talk about mindfulness and improving attention, one of the things that they're probably improving is this: they're trying to get the person to stop running that 15, 20% program all the time. And it's like your brain got upgraded because you can now devote yourself to the task in front of you. And the anxiety is not slowing you down or intruding upon you, either as an intrusive thought in an OCD way or just a sort of intrusive worry that's probably hampering your ability to do something concentration-intensive. And then if you have anxiety problems and you're not sleeping right, well, now your memory is impaired because of that. So, there's this cycle that ends up happening over and over again.  IS HYPERACTIVITY ANXIETY OR ADHD? Kimberley: Yeah, I think a lot of people as well that I've talked to clients and listeners, also with anxiety, there's this general physiological irritability. Like a little jitteriness, can't sit in their chair, which I think is another maybe way that misdiagnosis can -- it's like, “Oh, they're hyperactive. They're struggling to sit in their chair. That might be what's going on for them.” Is that similar to what you're saying?  Ryan: Yeah. So, really good example, and this one we can do a little simpler. I mean, the statement I'm going to say is not 100% true, but it's mostly true. If you are an adult, like over 25 for sure, and you are physically jittery, it is very unlikely that that is ADHD. Because ADHD, the whole mechanism as we understand it, or one of the mechanisms causing the thing we call ADHD, which of course is like a made-up thing that we're using to classify it, is that your prefrontal cortex is not done developing. So, it needs to get myelinated, which is essentially like -- think about it like upgrading from dial up to some great, not even a cable modem. You're going right to Verizon Fios. Like amazing, okay. It's much faster, and it's growing. And that's the part of you that makes you most human. That's the most sophisticated part of your brain. It's not the part that helps you breathe or some sort of physiological thing, which, by the way, is causing some of those anxiety symptoms. They're ramped up in a sympathetic nervous system way, fight or fight way. It's the part that's actually slowing you down. That's like, “Whoa, whoa, whoa, whoa, whoa, calm down, calm down, calm down.” This is why, and everyone's is not as developed. So, we're all developing this thing through 25, at least ADHD is through 28.   Car insurance goes down to 25 because your driving gets better, because your judgment gets better, because you can plan better, because you are less risk-taking. So, your insurance has now gone down. So, the insurance company knows this about us. And our FMRI scans, you scan people's brains, it supports that change. These correlate to some extent with symptomology, not enough to be a diagnosis to answer the person's question that they're going to have that. I wish it was. It's not a diagnosis. We haven't been able to figure out how to do that yet.   So, by the time you're 25, that's developed. And the symptoms that go away first with ADHD are usually hyperactivity, because that's the inability to manage all the impulses of your body, not in an anxious, stressed-out way, but in an excited way. You think of the happy, well-supported, running around ADHD kid is kind of silly and fun. It's a totally different mood experience than the anxiety experience. Anxiety experience is unpleasant for the most part. Unless your anxiety is targeting you to hyper-focus to get something done, which is bumping up some of your dopamine, which is again the opposite experience of probably having ADHD, it's a hyper-focus experience, certainly, the deficit part of ADHD, you're going to be feeling a different physiological, the irritability you talked about 100%. You're irritable because you are trying so hard to manage this awful feeling you have in your body. You physically feel so uncomfortable. It is intolerable.   I have this poor, anxious young man that has to do a very socially awkward thing today. Actually, not that socially awkward. He created the situation, which is one of the ways we're working on it with him in treatment. And I'm letting him go through and do this as an exposure because it'll be fine. And he's literally interacting with another one of our staff members. But he finds these things intolerable. He talks about it like we are lighting him on fire. So, he's trying to hold it together, or whatever your physiological experience is. It may not have been as dramatic as I described. You're irritable when people are asking things of you because you don't have much left. You're not in some carefree mood where you're like, “Whatever, I'm super easygoing. I don't care.” No, you're not feeling easygoing right now. You're very, very stressed out.   Stress and anxiety are very linked. Just like sadness and depression are very linked, and like loneliness and depression are linked, but they're not the same thing. Stress and anxiety are very, very linked, and they're similar feelings, and they're often occurring at the same time and interacting with each other. ADD vs. ADHD  Kimberley: Right. One question really quick. Just to be clear, what about ADD vs. ADHD?  Ryan: We love to change diagnostic criteria. People sit around. There's a committee, there's a whole bunch of studies. And we're always trying to epidemiologically and characterologically differentiate what these different conditions are. That's what the field is trying to do as an academic whole. And so, there's disagreements about what should be where. So, the OCD thing moving is one of them.   The ADD thing, it's like a nomenclature thing. So, the diagnosis got described that the new current version of the diagnosis is attention deficit hyperactivity disorder, and then you have three specifiers, okay? So, that's the condition you have. And then you can have combined, which is hyperactive and inattentive. Just inattentive, just hyperactive. And impulsive is built in there. So, it's really not that interesting. People love to be like, “No, no, I have ADD. No, I don't have the hyperactive.” And I'm like, “I know, but from a billing point of view, the insurance company will not accept that code anymore. It doesn't exist.” DOES ADHD OR ANXIETY IMPACT CONCENTRATION?  Kimberley: Yeah. So, just so that I know I have this right, and you can please correct me, is if you have this more neurological, like you said, condition of ADHD, you'll have that first, and then you'll get maybe some anxiety and some depression as a result of that condition. Whereas for those folks, if their primary was anxiety, it wouldn't be so much that anxiety would cause the ADHD. It would be more the symptoms of concentration are a symptom of the anxiety. Is that what you're saying? Ryan: Yes, and every permutation that you can imagine based on what you just said is also an option. Like almost every permutation. Like how are they interacting with each other? How are they making each other worse? How are they confusing each other? Because you can have anxiety disorders in elementary school. I mean, that is when most anxiety disorders, the first win, like the wave of them going up is then. And you think about all the anxiety you have.   I got a friend of mine who's got infants. And it's fun to see like as they're developing, when they go through normal anxiety, that that is a thing that they're going to pass. And then there's other things where, at some point, we're like, actually, now we're saying this is developmentally inappropriate, which means, nope, we were supposed to have graduated from this and it's still around.   And so, one of the earlier ways that psychiatric conditions were conceptualized, and it's still a useful way to conceptualize them, is the normal behavior version of it versus the non-normal behavior version of it. And again, I hate non-normal, I don't want to pathologize people, but non-normal being like, this is causing problems for you. And if you think about it from an evolutionary point of view, all of these conditions have pretty clear evolutionary bases of how they would be beneficial. Anxiety is going to save your ass, okay? Properly applied anxiety, it'll save your tribe. You want someone who's anxious, who's going to be like, “We do not have enough from this winter.” An ADHD person was like, “It'll be fine. I'm just going to go find something else.” And you're like, “No.” And then when that winter's really bad and you save that little bit of extra food, that 30% that the anxious person pushed for, maybe you didn't eat all 30% of it, but you know what, it probably benefited you and it might've actually made the whole tribe survive or more people survive or better health condition. So, it's approving everyone's outcomes.   The ADHD individual, you get them excited about something—gone. They're going to destroy it. They're going to find all the berries. They're going to find all the new places. They're going to find all the new deer. They're going to run around and explore. It's great. Great, great, great.   Depression is like hibernation. And if you look at hibernation in a mammal, like what happens, there's a lot of overlaps. Lower energy, maybe you store up some food for the winter. It's related to the seasons. You're in California, right? This is not a problem you have, but for those of us in New York, where we have seasonality, seasonal depression is a thing. It's very much a thing. It's very noticeable, and it's packed on top of these conditions everyone else is having.  But the idea is that the hibernation or the pullback is like something happens to you that upsets you, which is the psychosocial event that's kicking you in the face that might set off your depression. That's why people always say, “Oh, depressions just don't come out of nowhere. This biochemical thing isn't true.” What they're saying is something has to happen to start to kick off the depression, but that's not enough. It's that you then can't recover from it.   And so, a normal version of it is that you get knocked out and you spend a week or two, you think about it. Rumination is a part of depression for many people. You reevaluate, and you say, “You know, I got kicked in the face when I did that. That was not a good plan for me. I need a new plan. I either need to do something different or I need to tackle that problem differently.” And so, that would be the adaptive version of a depressive experience. Whereas the non-adaptive version is like, you get stuck in that and you can't get out.  Kimberley: Or you avoid.  Ryan: The avoiding doing anything about it, and then that makes it worse. So, you started withdrawing. I mean, that's the worst thing you can do. This is a message to everyone out there. The worst thing that you can do is withdraw from society for any period of time. Look, I'm not saying you can't have a mental health day, but systematic withdrawal, which most of us don't even realize is happening, is going to make you worse because the best treatment for every mental health condition is community. It is really. All of them. All of them, including schizophrenia.   I used to work in Atlanta. I did my residency. There'd be these poor guys that have a psychotic disorder. They hear voices. The kinds of people that, here in New York City, are homeless, they're not homeless there. Everyone just knows that Johnny's just a little weird and his mom lives down the street. And if we find Johnny just in the trash can or doing something strange, or just roving, we know he's fine, and someone just takes him back to his mom's house and checks on him. Because there's a community that takes care of him, even though he's actually quite ill from our point of view. But when you put him in an environment where that community is not as strong, like a city, it does worse, which is why mental health conditions are much higher rates in urban areas. Probably why psychiatry and mental health in general is such a central thing in New York City. TREATMENT FOR ADHD vs. ANXIETY  Kimberley: Yeah. Okay, let's talk quickly about treatment for ADHD. We're here always talking about the treatment for anxiety, but what would the research and what's evidence-based for ADHD if someone were to get that clinical diagnosis?  Ryan: So, you want to think about ADHD as a thing that we're going to try to frame for that person as much as how is it an asset, because it historically has made people feel bad about themselves. And so, there are positive aspects to it, like the hyper focus and excitability, and interest in things. And so, trying to channel into that and then thinking about what their deficits are. So, they're functional deficits. If you're talking adult population, functional deficits are going to be usually around executive functioning and organization planning. Imagine if you're like a parent of small children and you have untreated ADHD, you're going to be in crazy fight-or-flight mode all the time because there's so many things to keep track of. You have to keep track of your wife and their life. Kimberley: I see these moms. My heart goes out to them. Ryan: And they're probably anxious. And the anxiety is probably protecting them a little bit. Because what is the anxiety doing? You think about things over and over and over again, and you double check them. You know what that's not a bad idea for? Someone who's not detail-oriented, who's an ADHD person, who forgets things, and he gets disorganized. So, there's this thing where you're like, “Okay, there may actually be a balance going on. Can we make the balance a little bit better?” So, how do you organize yourself?  MEDICATIONS FOR ADHD Right now, there's a stimulant shortage. Stimulants are the most effective medication for reducing ADHD symptoms. They are the most effective biological intervention we have to reduce the impact of probably any psychiatric condition, period. They are incredibly effective, like 80, 90% resolution of symptoms, which is great. I mean, that's great. That's great news. But you also want to be integrating some lifestyle changes and skills alongside of that. So, how do you organize yourself better? I mean, that's like a whole talk, but like lists, prioritizing lists, taking tasks, breaking them down into smaller and smaller pieces. Where do you start? What's the first step? Chipping away. You know what? If you only go one mile a day for 30 days, you go 30 miles. That's still really far. I know you would have gone 30 miles that day, especially if you have ADHD, but you're still getting somewhere.  And so, that kind of prioritization is really, really important. And so, you can create that on your own. There are CBT-based resources and things to try to help with that. There are ADHD coaches that try to help with that. It's consistency and commitment around that. So, how do you structure your life for yourself? That poor PhD candidate really needs to structure their life because there is no structure to their life.  The other things we want to think about with that, I mean, really good sleep, physical exercise. People with ADHD, we see on FMRI scans when you scan someone's brain, there's less density of dopamine receptors, less dopamine activity. You want to get that dopamine up. That's what the medications are doing, is predominantly raising the dopamine. So, physical activity, aerobic exercise, in particular, is going to do that. Get that in every day, and look, it's good for you. It's good for you. There is no better treatment for every condition in the world other than exercise, particularly aerobic. It basically is good for everything. If you just had surgery, we still want you to get out and walk around. Really quickly, that actually improves your outcome as fast as possible. So, those are the things I like people to start with if they can do that, depending on the severity of what's going on, the impact, what other things have already been tried. Stimulant medications or non-stimulant medications like Wellbutrin, Strattera, Clonidine are also pretty effective. Methylphenidate products, which is what Ritalin is. Adderall products mixed in amphetamine salts, Vyvanse, these are very effective medications for it. There's a massive shortage of these medications that people are constantly talking about, and is really problematic and does not appear to have an endpoint because the DEA doesn't seem ready to raise the amount that they allow to be made because they are still recovering from the opioid crisis, which is ongoing. And so, they're worried about that. Really, they want to be very thoughtful about this. These medications have a very low-risk potential for misuse. In fact, people with ADHD, they appear to reduce the risk of developing a substance use disorder. It's the most common thing that people worry about. So, treatment actually reduces that.  That said, the worst -- I mean, I don't want to say the worst thing. I mean, people hate me. The really not great way to get psychiatric treatment is to show up to someone once and then intermittently meet with them where they write a prescription for a medication for you that's supposed to help you, and stimulant medications are included on that. So, that's probably why I didn't lead with that, even though there's actually more science to support them, is that by themselves, it's really going to limit how much help you're going to get. Kimberley: Can you share why? Ryan: Because you need to understand your condition, because you need to spend time with your clinician learning about your condition and understanding how it's affecting your life, and understanding how the medication is actually meant to be a tool. It should be like wearing glasses. It doesn't do the work for you. It doesn't solve all your problems, but it's easier to read when you put your glasses on than without it. It supports you. You still need to figure out how to get these things done. It lowers the activation energy associated with it. But you also want to monitor it. You can't take these medications 24 hours a day and just be ready to go and work, which is things that people have tried. It doesn't work because you need to sleep, because you will die. They've tried this. We know that you will literally die, like not sleeping. And in the interim, you are damaging yourself significantly. So, taking it and timing it in an appropriate way, still getting sufficient sleep, prioritizing other things—they are like a piece of a puzzle, and they are a really powerful piece. But you really don't want that to be the only thing driving your decision-making, or that be what the interaction is really about. And by the way, the same thing is true for all psychiatric medications. Kimberley: I was going to say that's what we know about OCD and anxiety disorders too. Medication alone is not going to cut you across the line.  Ryan: And for most people, therapy alone is also not going to cut the line. You have to have a mild case for therapy alone to be okay. And I can trouble for that statement. But the other thing is lifestyle. What lifestyle changes can I make? And those together, all three, are going to mean that you get better faster, you get more better than you would have, you're more likely to stay better. And they start to interact with each other in a good way, where you get this synergistic effect of ripples of good things happening to you and personal growth. You look back, and you're like, “Geez, I'm on version 3.0 of me. I didn't know that there was a new, refined personal growth version of me that could actually function much better. I didn't actually believe that.” DOES ADHD IMPACT SELF-ESTEEM?  Kimberley: Well, especially you talked about this impact to self-esteem too. So, if you're getting the correct treatment and now you're improving, as you go, you're like, “Okay, I'm actually smart,” or “I'm actually competent,” or “I'm actually creative. I had no idea.”   Ryan: Yes. “I'm not stupid.” Lots of people with ADHD think they're stupid.   Kimberley: Yeah. So, that's really cool. One question I have that's just in my mind is, does --  Ryan: And that should be part of your treatment, is the working through. That was essentially a complex trauma. It's the complex trauma of having this condition that may not have been treated that made you think that you were an idiot because you were being shoved into a situation that you did not know how to deal with because your ADHD evolved to be an advantage for you as a hunter-gatherer for the hundreds of thousands of years that we had that, and that modern world is not very compliant for. It doesn't experience you as fitting into it well. And then you feel bad about yourself. ADHD IN MALES vs. FEMALES  Kimberley: Right. You're the class clown, or you're the class fool, or the dumb girl, or whatever. Now, my last question, just for my sake of curiosity, is: does ADHD look different between genders?  Ryan: This is an area of significant research. So, historically, the party line has been that ADHD is significantly more common in boys and girls. And the epidemiology, the numbers, the prevalence have always supported that. Like 3 to 1, 2 to 1, like a much more, much more common. Refining of that idea has come up with a couple of thoughts. One, for whatever reason, I don't know how much of this is genetic. I have no idea how much of this is environmental, sociological. All other things being equal, after a certain young age, girls just always seem to be ahead of boys in their development. I mean, talk to any parent that's had a lot of kids, and they'll tell you that they're like, “I don't know why the girls are always maturing faster.” So, that's a bias that is going to always make at any given point. The boys look worse because their brains are not developed. So, they're going to be -- remember that immature younger thing? They're going to be immature and younger. And so at any given marker is that.  The other thing that's come up is that the hyperactivity seems to be something we see a lot more in males than in females. That's another thing. And versus inattentiveness, which you see in both and is usually the predominant symptom. And the kid who gets noticed is the little boy who's like -- I mean, not that you could do this in today's world, but has scissors and is about to cut a kid's cord. I'm trying to make a silly imagery. That kid's getting a phone call. No one didn't notice that. The whole class called that. Whereas like daydreaming, I'm not really listening—this is a more passive experience of ADHD. And they're not disrupting the room. Forget about the gender thing. Just that presentation is also less noticed.   So, I think the answer is the symptomology presentation is a little different. It tends to be predominantly hyperactive. Are the rates different? Yes, they're probably not as wide of a difference as we think they are, because we're probably missing a good number of girls. Are we missing enough girls to make it 50/50? I don't know. That would be a lot of -- it's a big gap. It's not close. It's a pretty big gap. Maybe we're certainly missing some.   And then the other aspect of it is particularly post-puberty. Even before puberty, there's hormonal changes going on. And these hormones, particularly testosterone, which is present in everyone, we think about it as a male thing, but it's really just like a balance thing. You have significant amounts of both. It affects a number of things, and attention is one of them. So, there's so many complexing factors to it. That's why I said, it's something we're still trying to sort out.   One of the things that's really interesting that goes back to the hormone thing is that if you talk to young women— so postmenstrual, they've gone through puberty—they will tell you over and over again that their symptomology, just like we have mood symptoms tend to be worse during that time period of when you're ovulating, the ADHD symptoms will be worse as well. And so, there's increasing evidence that if you're on ADHD medication and you have ADHD, which again, we're making lots of presumptions here, go get that confirmed, guys. But if you're on that time period just leading up to ovulation a little bit after, you may actually need a higher dose of your medication to get the same effect. That there's something about the way progesterone and whatever is changing that it affects functionally your attention and your experience of your symptomatology.   Kimberley: Interesting. Yeah, thank you for sharing that. Is there anything you feel like we've missed or a point you really want to make for the folks who are listening who are trying to really untangle, like you said, that imagery of untangle, anxiety, ADHD, all of the depression, self-esteem?  Ryan: This is like a sidebar that's related. So, one of my other areas of interest is cannabis. And here in New York, we've had a lot going on with cannabis. And there's a lot of science going on around, can cannabis be used to treat things, particularly psychiatric disorders? And I know that a lot of people are interested in that.  One of the things that I've been really trying to caution people around with it is that the original thing that I was probably taught in the ‘90s about cannabis, marijuana being like this incredibly unsafe thing, is not true. But the narrative that it's totally fine and benign is also not true. And that it is probably going to be effective in reducing anxiety acutely, and it will probably be effective in maybe even improving your mood. And some people with ADHD even think it improves their attention by calming their mind. I am very cautious about people starting to use that as part of their treatment plan. And I can tell you why.  Kimberley: Because you did say there's an increase in substance use.  Ryan: The problem is that it's not rolled out in a way that reflects an appropriate medical treatment. So, if you do it recreationally, obviously, it's basically like alcohol. You just get what you want, and you decide what you want. If you do it medically, depending on the state, as a general rule, you just get a medical card and then you decide what you're going to do, which just seems crazy to me. I mean, you don't do that. You don't send people home with an unlimited amount of something that is mind-altering and tell them to use as much as they need. And the potencies, the strength of it has gotten stronger and stronger.   And so, I really caution people around this because when you use it regularly, what ends up happening is you get this downregulation, particularly daily use. You get this downregulation of your receptors, your cannabinoid receptors. We all have cannabinoid receptors. And you have fewer and fewer of them. And because you have so much cannabinoid in your system because you're getting high that your body says, “I don't need these receptors.” So then when you don't get high, those cannabinoid receptors that modulate serotonin, dopamine—so functionally, your attention, your mood, your anxiety level—there's none of them left because they've been getting bound like crazy to this super strong thing. And you're making almost none yourself, so you're going to feel awful. You're going to feel awful. And it's not dosed in any kind of appropriate way. We're not giving people guidance on this.   So, I really caution people when they're utilizing this, which the reality is that a lot of people are, that they be thoughtful about that and thoughtful about the frequency that they're using and the amounts that they're using, and if they're at a point where they're really trying to self-medicate themselves, because that can really get out of control for people. They can get really out of control. And I think it's unfortunate that we don't have a better system to help people with that. That is more like the evaluation of an FDA-approved medication or something like that has a system through it.   So, I just wanted to add that because I know this is something that a lot of people are thinking about. And I think it can be hard to get really good science information on since there's a big movement around making this change. When we're doing a big movement around pushing for a change, we don't want to talk about the reasons that the change might be a little problematic, and therefore slow the change down. So, we forget about that. And I think for the general public, it's important to remember that.  Kimberley: Yeah, I'm so grateful that you did bring that up. Thank you. Where can our listeners learn more about you or be in touch with you?  Ryan: So, if they want to learn more about my practice, my clinical practice, integrativepsych -- no, integrative-psych.org. We changed. We wrote .nyc. There we go. And then if you want to learn about my science and my lab and our research, which we also love, if you just go to Sultan (my last name) lab.org, it redirects to my Columbia page, and then you can see all about that and send some positive vibes to my poor research assistants that work so hard.   Kimberley: Wonderful. I'm so grateful for you to be here. Really, I am. And just so happy that you're here. So much more knowledgeable about something that I am not. And so, I'm so grateful that you're here to bring some clarity to this conversation, and hopefully for people to really now go and get a correct assessment to define what's going on for them.  Ryan: Yeah, I hope everyone is able to digest all this. I said a lot. And can hopefully make better decisions for themselves for that. Thank you so much.  Kimberley: Thank you.

Interviewer: Dr. Lisa Meeks Interviewees: Dr. Lee Miller, Dr. Mijiza Sanchez-Guzman, Dr. Kama Guluma, Dr. Erick Hung, and Dr. Sharad Jain Description:  In this episode, we delve into the pivotal role of disability within medical education, particularly its significance in the realms of diversity, equity, inclusion, and justice. Joining us are leaders from California Medical Schools, including Dr. Lee Miller, Dr. Mijiza Sanchez-Guzman, Dr. Kama Guluma, Dr. Erick Hung, and Dr. Sharad Jain, who generously share their experiences and insights on the profound impact of disability within the medical field. Our discussion begins with an exploration of the catalysts driving the integration of specialized support systems for disability-related issues within medical schools. Our guests discuss the instrumental role of student advocacy groups in elevating the unique needs of students with disabilities and chronic illnesses and the imperative for specialized support. They also discuss the transformative effects of incorporating specialized Disability Resource Professionals (DRPs) within medical school frameworks. Our guests outline the myriad benefits associated with dedicated DRPs, ranging from heightened student satisfaction to an enriched curriculum that prioritizes disability-related matters with greater awareness and inclusivity. The guests further examine the strategic advantages inherent in investing in specialized support mechanisms, emphasizing the importance of fostering an inclusive community, eradicating stigmas surrounding disability in medicine, and cultivating a workforce that authentically reflects the diverse fabric of society. This conversation also confronts the challenges and valuable lessons learned from the implementation of specialized support programs. Our guests offer candid reflections on navigating transitions from external disability services to an in-house DRP, overcoming logistical obstacles, and garnering essential support from institutional leadership. Ultimately, this episode serves as a testament to the critical significance of specialized support for disability within medical education. It underscores the necessity of embracing inclusive practices, championing diversity and inclusion, and creating an environment where all students can thrive equitably. Bios Sharad Jain, MD is Professor of Medicine and Associate Dean for Students at the UC Davis School of Medicine. Dr. Jain completed medical school and residency in internal medicine at UCSF, where he was on faculty for several years.  Prior to coming to UC Davis, Dr Jain served as the residency director of the UCSF/SFGH Primary Care Medicine Residency Program where he focused on training primary care leaders in the care of vulnerable populations. At UC Davis, he focuses on supporting students from diverse backgrounds to excel in medical school through academic advising, wellness initiatives, career decision-making, community building, and ensuring a respectful learning environment. He practices general internal medicine at the Sacramento County Health Center, an FQHC affiliated with UC Davis. Dr. Erick Hung is a Professor of Clinical Psychiatry in the UCSF Department of Psychiatry and Behavioral Sciences and is a member of the UCSF Academy of Medical Educators. He is the Associate Dean for Students in the UCSF School of Medicine. Prior to joining the Dean's team, he served as the Program Director of the Adult Psychiatry Residency Training Program from 2012-2022 and the Director of Curricular Affairs for GME for the UCSF School of Medicine from 2015-2022. He completed his medical school, psychiatry residency, and forensic psychiatry fellowship training at the University of California, San Francisco and joined the faculty at UCSF in 2009. He actively teaches in the areas of risk assessment, medical education, forensic psychiatry, leadership, and ethics. His interests include primary care and mental health integration, the interface between mental health and the legal system, inter-professional collaboration and training, HIV psychiatry, LGBTQ mental health, and medical education. His educational scholarship interests include competency-based assessment, faculty development, and near-peer learning in the workplace setting.  Kama Z. Guluma, MD, is a Clinical Professor of Emergency Medicine and the Associate Dean for Admissions and Student Affairs at UC San Diego School of Medicine. As the Associate Dean for Admissions and Student Affairs, he oversees the offices of Admissions, Student Affairs, and Financial Aid. Dr. Guluma joined the Department of Emergency Medicine as a faculty member in 2001. He joined the Division of Medical Education as Associate Dean for Admissions and Student Affairs in October 2018. Prior to becoming Associate Dean, he served as the Director of Student Programs for the Department of Emergency Medicine, and as an Academic Community Director in the UC San Diego School of Medicine. He is a past recipient of the Medical Student Teaching Award in the UC San Diego Department of Emergency Medicine, has been a nominee for the Kaiser Excellence in Teaching Award in the UC San Diego School of Medicine, and a recipient of the Faculty Mentorship Award from the UC San Diego Graduate Student Association. Lee Todd Miller, MD is Professor of Pediatrics and the Associate Dean for Student Affairs at the David Geffen School of Medicine at UCLA. After completing medical school and post-graduate training at the University of Virginia, for the last 38 years, Dr. Miller has been heavily involved at UCLA in both undergraduate and graduate medical education in pediatrics. Prior to moving into the Dean's Office, he served for 10 years as the Vice Chair of Education within the Department of Pediatrics. He is the 12-time recipient of the UCLA School of Medicine's Golden Apple Award, the national Humanism in Medicine Award sponsored by the Association of American Medical Colleges, and the University of California Academic Senate Distinguished Teaching Award. In addition to his current roles in Student Affairs and pediatric education, Dr. Miller is also one of the founders of the medical school's Global Health Program, nurturing the global health interests of countless students and residents over the years. He has worked on education-related projects in the Democratic Republic of the Congo, Ethiopia, Mozambique, Rwanda, South Africa, Zambia, Afghanistan, Myanmar, Peru, and Ecuador. Mijiza M. Sanchez-Guzman is the Associate Dean, Office of Medical Student Affairs, at the Stanford School of Medicine. She has worked in higher education and the health sciences for more than 18 years with a commitment to diversity and inclusion, gender equity, and leadership development. Transcript Keywords: DRP, Disability Inclusion, Medical Education, Leadership, Students, Structures, Processes, Specialized Support. Produced by: Lisa Meeks  Audio editor: Nicole Kim Digital Media: Katie Sullivan and Lisa Meeks  

Today's disagreement is about ADHD and its meteoric rise in the United States.Specifically, what are the causes of ADHD? Is it biological or environmental or both? And given that, what is the right approach to medicating and treating our children?In today's episode: two health experts with very different perspectives on ADHD. The GuestsMarilyn Wedge (Phd, LMFT) is a practicing Family Therapist in Westlake, CA and author of A Disease called Childhood: Why ADHD Became an American Epidemic. She holds a Phd in Social Psychology from the University of Chicago.Ryan Sultan (MD) is Assistant Professor of Clinical Psychiatry at Columbia University Irving Medical Center and New York State Psychiatric Institute. Ryan is a national expert on ADHD and cannabis use. Show NotesWhat is ADHD? [04:10]How does the home environment impact ADHD symptoms? [10:53]Use of medication when nothing else works [14:22]Does ADHD exist? [17:05]Skyrocketing U.S. rates of ADHD [19:07]Is ADHD a disease or a constellation of traits? [20:54]Conflation of ADHD and other mental health disorders [32:00]ADHD underdiagnosis pre-2000s? [34:26]The use of amphetamines in treating ADHD [36:45]Side effects of ADHD medication [39:16]How and why schools identify ADHD in children [45:15]Ryan's personal story with ADHD [46:14]Gender differences in diagnosis rates [52:19]Steelmanning [54:03] ResourcesThe original 1937 article by Dr. Charles Bradley about the impact of benzedrine on children in the American Journal of PsychiatryADHD Nation: Children, Doctors, Big Pharma, and the Making of an American Epidemic by Alan SchwarzThe ADHD Advantage by Dale Archer

What are the cultural factors that should be considered when providing mental health care to migrant and refugee populations? What challenges and opportunities exist in providing mental health care to these communities? How can mental health professionals collaborate with other disciplines to create a holistic approach to address the mental health needs of migrant and refugee populations?  Lisa Fortuna, MD, MPH is the Chief of Psychiatry and Neurosciences at the Riverside School of Medicine. She was the Chief of Psychiatry and Vice-Chair at Zuckerberg San Francisco General Hospital/UCSF and Associate Professor of Clinical Psychiatry. She has been an investigator on several National Institutes of Health and foundation-funded studies of Latino and immigrant mental health, integrated care, access to care including a principle investigator of a NIMH funded R01 aimed at optimizing family navigation for addressing child behavioral health in primary care and a Patient Centered Outcome Research Institute (PCORI) funded multi-site large pragmatic trial on the treatment of childhood anxiety comparing face to face vs. digitally delivered CBT in English and Spanish called Kids FACE FEARS. Her areas of expertise are child and adolescent psychiatry, treatment and research on PTSD across the lifespan, immigrant mental health and disparities/ access to care including digital interventions research. 

This week, Marianna revisits an episode with Francine Cournos, Professor of Clinical Psychiatry, and Stephen Abel, Associate Professor at the University at Buffalo School of Dental Medicine, where they talk about the connection between oral health and mental health, especially when it comes to people with HIV.--Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=UUO5439) --Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-coursesDownload our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

Over 2,400 years ago, Greek physician Hippocrates first detailed symptoms of "opposite" mood states - what we now understand as mania and depression. Throughout the Middle Ages and into the modern era, vivid descriptions of melancholy and euphoria continued to surface, drawing focus to a set of distinct symptoms that appeared to occur in cycles. In this special talkBD episode, psychiatrist Dr. Manuel Sánchez de Carmona dives through centuries of evidence to uncover the fascinating story of manic-depression - and how we've come to know the condition today as "bipolar disorder". (00:00) Introduction (01:54) Virginia Woolf Knew She Was Ill (03:58) Ancient Greece & Rome (09:22) 19th Century France & Germany (14:18) The Circular Pattern of Bipolar Disorder (18:52) The Modern Era (21:00) The Bipolar Spectrum (24:14) The DSM & History of Mixed Features (27:04) Today: Key Figures, Advocacy, World Bipolar Day (31:50) The Term "Bipolar Disorder" Is Inaccurate? (35:20) King George III & Life Charting (41:49) Learning from Your History People referenced Ancient & Classical: Hippocrates, Aristotle, Aretaeus of Cappadocia, Posidonius 19th Century: Jean-Pierre Falret, Jules Baillarger, Karl Kahlbaum, Emil Kraepelin, Vincent van Gogh, King George III Modern Era: Virginia Woolf, Karl Leonhard, Jules Angst, David Kupfer, Ellen Frank Today: Kurt Cobain, Carrie Fisher, Kanye West, Britney Spears Share this episode: http://bipolarhistory.com Dr. Manuel Sánchez de Carmona is a member of the ISBD Board of Directors and works as an associate professor of Clinical Psychiatry for the Anahuac University in Mexico City, Mexico. He began his involvement with ISBD in 2008 as the founder of the ISBD Mexican Chapter and since then in key leadership roles: first as ISBD Secretary Treasurer and then as ISBD President, serving for two consecutive terms from March 2014 to December 2017. He was able to actively promote the Society and generate local chapters in several countries of Latin America, Asia, and Europe. He is passionate about providing education on bipolar disorders and using the Society as a game-changer in public mental health services. Since World Bipolar Day's inception, he has been involved in its global promotion and making connections with experts with the lived experience to generate community awareness and fight stigma. Dr. Sanchez de Carmona has more than 30 years of clinical experience treating mood disorders and is interested in diagnosis, early detection, and providing quality of life to patients. This episode is hosted by Dr. Erin Michalak and produced by Caden Poh. #talkBD Bipolar Disorder Podcast talkBD gathers researchers, people with lived experience, healthcare providers, and top bipolar disorder experts from around the world to discuss and answer the most important questions about living with bipolar disorder. Learn more about talkBD: ⁠⁠⁠⁠https://talkBD.live

Click here for the video that accompanies this podcast.  Dr. Maren Nyer is the Director of Yoga Studies and the Associate Director of the Research Coordinator Program at the Depression Clinical and Research Program (DCRP), Massachusetts General Hospital (MGH). She is an Assistant Professor of Psychiatry at Harvard Medical School (HMS). Her research interests include the treatment of mood disorders and associated symptoms, specifically developing and evaluating innovative and complementary and integrative treatments for depression. She completed her pre-doctoral psychology internship at MGH/HMS. After that, she worked as a post-doctoral fellow at the DCRP, until obtaining a staff position in September, 2012. She holds a BA in Psychology from Cornell University and a PhD in Clinical Psychology from the University of Virginia. Click here to view Dr. Nyer's research.She was the principal investigator for the clinical trial on how hot yoga may reduce depression, which was published in the Journal of Clinical Psychiatry. Here's what Nyer said about the study: This study was a more rigorous follow up to an original, open study that we did with heated yoga. The results suggested antidepressant benefit, so the next step was to do a controlled study with a larger patient sample. We recruited 80 patients with depression, and randomly assigned half of them to heated yoga (which they could attend at any of two affiliated yoga studios that collaborated with our team) and the other half to a waiting list as a control intervention, both for 8 weeks. Patients were encouraged to attend at least twice weekly or more, depending on their schedule and availability of classes. We found that people who received the heated yoga intervention experienced a significantly greater improvement in depressive symptoms, compared to the patients who were assigned to the waiting list. They received these benefits attending only approximately one class per week.

Liza Mundy is the bestselling author of Code Girls, a book about the American women who broke codes during the Second World War. Her new book details the lives of spies and intelligence agents behind some of the biggest operations in postwar history including locating Osama bin Laden, and rescuing the schoolgirls kidnapped by Boko Haram. Around 80 Israeli rights groups have signed a letter calling on the organisation UN Women to condemn acts of violence against women by Hamas. The letter was addressing a statement issued by UN Women, a United Nations entity which aims to be a global champion of women and girls – which they said ‘ignored the atrocities that took place on Oct 7th'. Emma Barnett speaks to Tal Hochman from the Israeli Women's Network who are one of the organisations involved and also by Lyse Doucet the BBC's Chief International Correspondent. According to a new trial published in the journal of Clinical Psychiatry involving 80 people from Massachusetts General Hospital - heated yoga sessions could lead to reduced depressive symptoms in adults with moderate-to-severe depression. The trial findings suggest that the combination of yoga and heat should be considered as a potential treatment for individuals experiencing depression. Hot yoga instructor Cindy Thomas and writer and broadcaster Laura Barton talk about the survey. Ruth Birch and Julia Curry are a couple from South Wales. They met as young women in the British army, but had to leave because of the pressure they were under to lie about their sexuality and conceal their relationship. You were not allowed to be gay or lesbian in the UK military until the year 2000. The stress led to them breaking up, but twenty years later they reunited, and now campaign on behalf of fellow LGBT veterans. Ruth and Ju feature on You Had Me at Hello, a podcast where ordinary people tell their love stories. Presenter: Emma Barnett Producer: Lisa Jenkinson Studio Manager: Giles Aspen

Welcome back to a brand-new season of the miniVHAN podcast, where together we learn more about mental health across the lifespan—and how physical, mental and emotional health are all interconnected. Joining us first in the miniVHAN are two health care experts who will examine the signs and symptoms of anxiety and depression, and help us recognize the signals that further clinical support is needed. Have ideas to share or want to be a guest on the miniVHAN podcast? Contact us anytime at minivhanpodcast@vhan.com. Guests this episode: Susan O'Hara, MSW, LCSW, Vanderbilt University Medical Center, Psychiatry and Behavioral Sciences, Psychotherapist | Dr. Jason Greenhagen, Vanderbilt University Medical Center, Director of Inpatient Geriatric Psychiatry Service, Director of Long-Term Care Psychiatric Service, Assistant Professor of Clinical Psychiatry and Behavioral Sciences 

This week, Marianna sits down with Francine Cournos, Professor of Clinical Psychiatry, and Stephen Abel, Associate Professor at the University at Buffalo School of Dental Medicine, to talk about the connection between oral health and mental health, especially when it comes to people with HIV. --Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=UUO5439) 

This episode is sponsored by Charm Economics.  In this podcast episode, Dr. Robert McCarron discusses the urgent need for improved mental health training for primary care physicians and specialists. As the founding director of the UC Davis Train New Trainers Primary Care Psychiatry Fellowship, Dr. McCarron aims to expand access to mental healthcare delivery, emphasizing the importance of addressing both physical and emotional pain in patients. The episode covers three key components of treatment: therapy, medication, and whole person care. Dr. McCarron advocates for empowering patients in decision-making and planting the seed for treatment, rather than pushing them into therapies they may not be ready for. He provides an overview of commonly used antidepressants like SSRIs and SNRIs and highlights the challenges of finding therapists due to the shortage of psychiatrists and insurance complexities.  His training program equips primary care providers with brief psychotherapy skills, such as cognitive behavioral therapy and motivational interviewing, to initiate treatment while patients wait for specialized care, ensuring better mental health support overall. Looking for something specific? Here you go! [00:05:00] Introduction to the Train New Trainers Primary Care Psychiatry Fellowship program. [00:06:00] The importance of training primary care providers in addressing mental health issues. [00:10:00] Approaching patients with stigma against mental illness and behavioral health conditions. [00:13:00] Integrative or whole person care as an essential component of treatment. [00:19:00] Overview of different antidepressant medications (SSRIs, SNRIs, Wellbutrin, Remeron). [00:22:00] Challenges in finding a therapist and the need for increased mental health resources in primary care. [00:23:00] Mini therapies and training primary care providers to address mental health. Bio/links! Dr. Robert McCarron, D.O., is a board-certified psychiatrist and internist, having completed a dual residency in internal medicine and psychiatry at Rush University. As the founding training director of the combined internal medicine/psychiatry residency program at the University of California, Davis School of Medicine, he received a prestigious 2.6 million dollar grant from the California Department of Mental Health. This grant aims to establish a comprehensive "Med Psych" curriculum that can be adopted by other primary care practitioner training programs, reflecting his dedication to enhancing mental health training in primary care. With a focus on unexplained physical complaints, depression, anxiety in primary care, and metabolic syndrome, Dr. McCarron has published extensively in these areas. He holds significant leadership roles, including the immediate past president of the Central California Psychiatric Society and the Association of Medicine and Psychiatry. Additionally, he serves as the Medicine/Psychiatry Section editor for Current Psychiatry and an Associate Editor for The Primary Care Companion to the Journal of Clinical Psychiatry. Dr. McCarron's contributions to various psychiatric associations and assemblies underscore his commitment to advancing general medical and psychiatric research, patient care, and medical education in California and beyond. Find Dr. McCarron on his LinkedIn.  Did ya know…  You can also be a guest on our show? Please email me at brad@physiciansguidetodoctoring.com to connect or visit www.physiciansguidetodoctoring.com to learn more about the show! Socials: @physiciansguidetodoctoring on FB  @physicianguidetodoctoring on YouTube @physiciansguide on Instagram and Twitter

In this episode, Xavier Bonilla has a dialogue with Frank Putnam about our various states of being. They discuss states of being, the continuous self, and states of being in development. They also talk about different states of being in rapid cycling with those that have Bipolar Disorders, importance of memory, and how critical is personality and the Big-5. They discuss mental disorders within a state model, the fragmented self and therapy, trauma and PTSD, Dissociative Identity Disorder (DID), psychedelics, and many more topics. Frank Putnam is a Physician and Professor of Clinical Psychiatry at the University of North Carolina School of Medicine. He was formerly a Professor of Pediatrics and Child Psychiatry at Children's Hospital Medical Center, University of Cincinnati College of Medicine. He is an esteemed research on topics of violence, abuse, DID, and trauma. He is the author numerous books including, The Way We Are: How States of Mind Influence Our Identities, Personality, and Potential for Change. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit convergingdialogues.substack.com

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Sharon Parish is a Professor of Medicine in Clinical Medicine and Clinical Psychiatry at Weill Cornell Medical College and a prominent sexual medicine specialist who has been practicing for 30 years. In this episode, Sharon tackles the topic of women's sexual health, including the conditions associated with decreased sexual function and desire and available treatment options. She explores the influence of sexual health on overall well-being while also examining the potential effects of childbirth, birth control, metabolic health, and more on sexual function and desire. Through case studies, Sharon teases apart the differences between desire and arousal, explains the various factors that affect them, and walks through hypothetical treatment plans for the case study patients. In addition, she delves into the subject of menopause, addressing its impact on sexual health as well as the misguided fears around hormone replacement therapy. Stay tuned for next week's launch of our complementary podcast on men's sexual health. We discuss: Sharon's interest in sexual medicine and the current state of the field [3:00]; How hormones change in women over time and how that impacts sexual function [8:15]; Changes after childbirth and its impact on sexual function [11:00]; The role of metabolic health and systemic vascular health in sexual health [20:15]; Conditions associated with decreased sexual function and the importance of sexual health for overall wellbeing [26:15]; Sexual dysfunction case study #1: A 41-year-old mother of two, the sexual response cycle, and the difference between arousal and desire [38:45]; Medications that may reduce sexual desire [49:45]; The effect of birth control pills on sexual desire [56:30]; The importance of testosterone in women for sexual function and desire, and why the FDA hasn't approved exogenous testosterone as a therapeutic [1:01:15]; Challenges faced by physicians who are open to prescribing off-label testosterone for women, and Sharon's approach in managing this aspect with her patients [1:14:30]; A hypothetical treatment plan for the patient in case study #1 [1:26:45]; The role of DHEA (a precursor to testosterone) in female sexual health [1:32:15]; Case study #2: A 30-year-old woman with anorgasmia (inability to orgasm) [1:38:30]; Resources for helping women and their partners to enhance the pleasure experienced during sex, overcome anxiety, and increase desire [1:51:30]; Two drugs for premenopausal women with low desire [1:59:30]; Why treatments are potentially underutilized for both desire and genitourinary syndrome of menopause [2:13:15]; Case study #3: A menopausal woman with symptoms [2:19:00]; Addressing the misguided fears around hormone replacement therapy and cancer [2:24:15]; Symptoms and treatment of genitourinary syndrome of menopause [2:32:45]; Age 65 and beyond, and resources for finding a provider [2:37:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

In this episode we meet Joseph Loizzo, MD, PhD, who is a Harvard-trained psychiatrist and Columbia-trained Buddhist scholar with over forty years' experience studying the beneficial effects of contemplative practices on healing, learning and development. Joe shares his story of founding the Nalanda Institute, in NYC, as an intersection between contemplative approaches from Buddhism, Psychology and Psychotherapy. The discussion focuses on the benefits and challenges of the practitioner model and Joe shares his approaches to rigorous engagement between his training as an MD and his practice in the Tantric Buddhist tradition. The discussion turns to cross-cultural research frameworks and we discuss his article, "Contemplative Psychotherapy," which is the introduction to a new volume he is the editor of called, Advances in Contemplative Psychotherapy: Accelerating Healing and Transformation (Routledge, 2023). In this article Joe speaks of the central importance of transformation of the body and how it can be beneficial to start approaching the idea of embodiment through the principals of spaciousness and light, based upon the Buddhist notions of the subtle bodies. Joseph (Joe) Loizzo is Assistant Professor of Clinical Psychiatry in Integrative Medicine at Weill Cornell Medical College, where he researches and teaches contemplative self-healing and optimal health. He has taught the philosophy of science and religion, the scientific study of contemplative states, and the Indo-Tibetan mind and health sciences at Columbia University, where he is Adjunct Assistant Professor at the Columbia Center for Buddhist Studies. East-West Psychology Podcast Website Connect with EWP: Website • Youtube • Facebook Produced by: Stephen Julich and Jonathan Kay Edited and Mixed by: Jonathan Kay Music at the end of the episode: Eventide, by Justin Gray and Synthesis, released on Monsoon-Music Online Record Community Introduction Voiceover: Roche Wadehra Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In this episode we meet Joseph Loizzo, MD, PhD, who is a Harvard-trained psychiatrist and Columbia-trained Buddhist scholar with over forty years' experience studying the beneficial effects of contemplative practices on healing, learning and development. Joe shares his story of founding the Nalanda Institute, in NYC, as an intersection between contemplative approaches from Buddhism, Psychology and Psychotherapy. The discussion focuses on the benefits and challenges of the practitioner model and Joe shares his approaches to rigorous engagement between his training as an MD and his practice in the Tantric Buddhist tradition. The discussion turns to cross-cultural research frameworks and we discuss his article, "Contemplative Psychotherapy," which is the introduction to a new volume he is the editor of called, Advances in Contemplative Psychotherapy: Accelerating Healing and Transformation (Routledge, 2023). In this article Joe speaks of the central importance of transformation of the body and how it can be beneficial to start approaching the idea of embodiment through the principals of spaciousness and light, based upon the Buddhist notions of the subtle bodies. Joseph (Joe) Loizzo is Assistant Professor of Clinical Psychiatry in Integrative Medicine at Weill Cornell Medical College, where he researches and teaches contemplative self-healing and optimal health. He has taught the philosophy of science and religion, the scientific study of contemplative states, and the Indo-Tibetan mind and health sciences at Columbia University, where he is Adjunct Assistant Professor at the Columbia Center for Buddhist Studies. East-West Psychology Podcast Website Connect with EWP: Website • Youtube • Facebook Produced by: Stephen Julich and Jonathan Kay Edited and Mixed by: Jonathan Kay Music at the end of the episode: Eventide, by Justin Gray and Synthesis, released on Monsoon-Music Online Record Community Introduction Voiceover: Roche Wadehra Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode we meet Joseph Loizzo, MD, PhD, who is a Harvard-trained psychiatrist and Columbia-trained Buddhist scholar with over forty years' experience studying the beneficial effects of contemplative practices on healing, learning and development. Joe shares his story of founding the Nalanda Institute, in NYC, as an intersection between contemplative approaches from Buddhism, Psychology and Psychotherapy. The discussion focuses on the benefits and challenges of the practitioner model and Joe shares his approaches to rigorous engagement between his training as an MD and his practice in the Tantric Buddhist tradition. The discussion turns to cross-cultural research frameworks and we discuss his article, "Contemplative Psychotherapy," which is the introduction to a new volume he is the editor of called, Advances in Contemplative Psychotherapy: Accelerating Healing and Transformation (Routledge, 2023). In this article Joe speaks of the central importance of transformation of the body and how it can be beneficial to start approaching the idea of embodiment through the principals of spaciousness and light, based upon the Buddhist notions of the subtle bodies. Joseph (Joe) Loizzo is Assistant Professor of Clinical Psychiatry in Integrative Medicine at Weill Cornell Medical College, where he researches and teaches contemplative self-healing and optimal health. He has taught the philosophy of science and religion, the scientific study of contemplative states, and the Indo-Tibetan mind and health sciences at Columbia University, where he is Adjunct Assistant Professor at the Columbia Center for Buddhist Studies. East-West Psychology Podcast Website Connect with EWP: Website • Youtube • Facebook Produced by: Stephen Julich and Jonathan Kay Edited and Mixed by: Jonathan Kay Music at the end of the episode: Eventide, by Justin Gray and Synthesis, released on Monsoon-Music Online Record Community Introduction Voiceover: Roche Wadehra Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/buddhist-studies

In this episode we meet Joseph Loizzo, MD, PhD, who is a Harvard-trained psychiatrist and Columbia-trained Buddhist scholar with over forty years' experience studying the beneficial effects of contemplative practices on healing, learning and development. Joe shares his story of founding the Nalanda Institute, in NYC, as an intersection between contemplative approaches from Buddhism, Psychology and Psychotherapy. The discussion focuses on the benefits and challenges of the practitioner model and Joe shares his approaches to rigorous engagement between his training as an MD and his practice in the Tantric Buddhist tradition. The discussion turns to cross-cultural research frameworks and we discuss his article, "Contemplative Psychotherapy," which is the introduction to a new volume he is the editor of called, Advances in Contemplative Psychotherapy: Accelerating Healing and Transformation (Routledge, 2023). In this article Joe speaks of the central importance of transformation of the body and how it can be beneficial to start approaching the idea of embodiment through the principals of spaciousness and light, based upon the Buddhist notions of the subtle bodies. Joseph (Joe) Loizzo is Assistant Professor of Clinical Psychiatry in Integrative Medicine at Weill Cornell Medical College, where he researches and teaches contemplative self-healing and optimal health. He has taught the philosophy of science and religion, the scientific study of contemplative states, and the Indo-Tibetan mind and health sciences at Columbia University, where he is Adjunct Assistant Professor at the Columbia Center for Buddhist Studies. East-West Psychology Podcast Website Connect with EWP: Website • Youtube • Facebook Produced by: Stephen Julich and Jonathan Kay Edited and Mixed by: Jonathan Kay Music at the end of the episode: Eventide, by Justin Gray and Synthesis, released on Monsoon-Music Online Record Community Introduction Voiceover: Roche Wadehra Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/psychology

In this week's episode of the podcast, we interview Dr. Michael Garrett, Professor Emeritus of Clinical Psychiatry and former Vice Chair and Director of Psychotherapy Education at SUNY Downstate Medical Center, Brooklyn, NY. He also wrote a book called, Psychotherapy for Psychosis: Integrating Cognitive-Behavioral and Psychodynamic treatment. He is husband to the prior beloved presenter, Dr. Nancy McWilliams. In this episode, we will discuss how psychotherapy can be effective for patients experiencing psychosis.    Full blog here.

This episode of Chitheads is a talk from Joe Loizzo republished from Embodied Philosophy's Yoga Seminar.  It's a taste of a deeper dive with Dr. Joe Loizzo in our upcoming 30-hr Certificate Program, “Buddhist Psychology in the Nalanda Tradition,” co-presented with the Nalanda Institute for Contemplative Science. To learn more or to take advantage of the Early Bird pricing (before May 19), go here. About the Guest Joseph (Joe) Loizzo, MD, Ph.D., is a Harvard-trained psychiatrist and Columbia-trained Buddhist scholar with over forty years of experience studying the beneficial effects of contemplative practices on healing, learning, and development. Joe is the Founder & Academic Director of the Nalanda Institute. He is Assistant Professor of Clinical Psychiatry in Integrative Medicine at Weill Cornell Medical College, where he researches and teaches contemplative self-healing and optimal health. He has taught the philosophy of science and religion, the scientific study of contemplative states, and the Indo-Tibetan mind and health sciences at Columbia University, where he is Adjunct Assistant Professor at the Columbia Center for Buddhist Studies. In this episode, we discuss: The philosophy of science from a Western point of view and practice. The history and context of the mind-body split in Western science. Research on stress and neuroplasticity that shed light on the mind-body connection.  Buddhist and scientific definitions of the mind and consciousness.  The question of where do I find my mind? A multi-disciplinary paradigm of mind-brain integration. Yoga as the science of integrating the human nervous system, mind, and body with awareness.   Select slides from Joe's Talk here.See omnystudio.com/listener for privacy information.

La cinquième version du DSM (Diagnostic and Statistical Manual of Mental Disorders) identifie comme dépression tout tableau associant plusieurs symptômes pendant au moins deux semaines, parmi lesquels l'humeur dépressive et/ou la perte de plaisir et d'intérêt. Si la sexualité n'est pas directement abordée dans le manuel, elle reste quasiment toujours impactée par la dépression et son évolution, soit directement, soit indirectement par le biais des traitements. Libido et dépression : un lien physiologique clair D'après une étude publiée dans le Journal of Clinical Psychiatry en 2002, jusqu'à 70% des personnes qui souffrent de dépression majeure font également état d'une baisse de libido. La dépression est associée à une diminution des niveaux de dopamine et de sérotonine, des neurotransmetteurs impliqués dans la gestion de l'humeur. Quand on sait que ces composés influencent le désir sexuel, on comprend que le rapport entre la dépression et la baisse de libido est étroit d'un point de vue physiologique. L'anhédonie sexuelle, c'est-à-dire la difficulté à ressentir du plaisir ou de la satisfaction lors des rapports, est aussi liée à la perturbation hormonale que la dépression induit au niveau de la testostérone et des œstrogènes. En outre, les changements de régulation de la récompense et du plaisir en phase dépressive favorisent l'insatisfaction sexuelle. D'après une étude menée par la Harvard Medical School en 2012, les personnes dépressives ont deux fois plus de risques de développer une anhédonie sexuelle. Les conséquences physiques de la dépression sur la fonction sexuelle Au-delà d'une modification du désir, la dépression induit aussi un changement dans la qualité de fonctionnement des organes sexuels. Les hommes souffrent alors de dysfonction érectile, d'éjaculation précoce ou retardée, tandis que les femmes connaissent une baisse de lubrification vaginale et une augmentation de la douleur lors des rapports, nommée dyspareunie. Lorsque la dépression s'accompagne d'une perte importante de poids ou, au contraire, d'une prise rapide de poids, elle modifie considérablement l'équilibre hormonal et la conscience que la personne a de son corps. Celle-ci peut se sentir moins désirable, étrangère à ses sensations ou à son propre corps. Les traitements anti-dépresseurs et leur impact sur la sexualité Il ne faut pas oublier de mentionner que les médicaments utilisés pour traiter la dépression présentent un impact considérable sur la libido et la fonction sexuelle. Ainsi, les inhibiteurs de la recapture de la sérotonine peuvent faire baisser la libido, provoquer des difficultés d'érection, des problèmes pour connaitre un orgasme ou une baisse générale du plaisir sexuel. Le rapport bénéfice/risque du médicament doit alors être évalué par le patient et le médecin afin d'établir l'intérêt ou non de poursuivre le traitement. Learn more about your ad choices. Visit megaphone.fm/adchoices

La cinquième version du DSM (Diagnostic and Statistical Manual of Mental Disorders) identifie comme dépression tout tableau associant plusieurs symptômes pendant au moins deux semaines, parmi lesquels l'humeur dépressive et/ou la perte de plaisir et d'intérêt. Si la sexualité n'est pas directement abordée dans le manuel, elle reste quasiment toujours impactée par la dépression et son évolution, soit directement, soit indirectement par le biais des traitements.Libido et dépression : un lien physiologique clairD'après une étude publiée dans le Journal of Clinical Psychiatry en 2002, jusqu'à 70% des personnes qui souffrent de dépression majeure font également état d'une baisse de libido. La dépression est associée à une diminution des niveaux de dopamine et de sérotonine, des neurotransmetteurs impliqués dans la gestion de l'humeur. Quand on sait que ces composés influencent le désir sexuel, on comprend que le rapport entre la dépression et la baisse de libido est étroit d'un point de vue physiologique.L'anhédonie sexuelle, c'est-à-dire la difficulté à ressentir du plaisir ou de la satisfaction lors des rapports, est aussi liée à la perturbation hormonale que la dépression induit au niveau de la testostérone et des œstrogènes. En outre, les changements de régulation de la récompense et du plaisir en phase dépressive favorisent l'insatisfaction sexuelle. D'après une étude menée par la Harvard Medical School en 2012, les personnes dépressives ont deux fois plus de risques de développer une anhédonie sexuelle.Les conséquences physiques de la dépression sur la fonction sexuelleAu-delà d'une modification du désir, la dépression induit aussi un changement dans la qualité de fonctionnement des organes sexuels. Les hommes souffrent alors de dysfonction érectile, d'éjaculation précoce ou retardée, tandis que les femmes connaissent une baisse de lubrification vaginale et une augmentation de la douleur lors des rapports, nommée dyspareunie.Lorsque la dépression s'accompagne d'une perte importante de poids ou, au contraire, d'une prise rapide de poids, elle modifie considérablement l'équilibre hormonal et la conscience que la personne a de son corps. Celle-ci peut se sentir moins désirable, étrangère à ses sensations ou à son propre corps.Les traitements anti-dépresseurs et leur impact sur la sexualitéIl ne faut pas oublier de mentionner que les médicaments utilisés pour traiter la dépression présentent un impact considérable sur la libido et la fonction sexuelle. Ainsi, les inhibiteurs de la recapture de la sérotonine peuvent faire baisser la libido, provoquer des difficultés d'érection, des problèmes pour connaitre un orgasme ou une baisse générale du plaisir sexuel. Le rapport bénéfice/risque du médicament doit alors être évalué par le patient et le médecin afin d'établir l'intérêt ou non de poursuivre le traitement. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

We reached out to Dr. Nathaniel Morris after reading his recent article in the New England Journal of Medicine; Injustice Disorder. Dr. Morris is currently an Assistant Professor of Clinical Psychiatry at the University of California San Francisco and provides care to incarcerated patients in the San Francisco jail system. He has published numerous journal articles on mental health care in jails and prisons, the criminalization of people with mental illness and addiction, and other topics in psychiatry and the law. Other publications include; Cell Front: The House Calls of Mass Incarceration in Annals of Internal Medicine; From Crime to Care - On the Front Lines of Decarceration in NEJM; and Addressing Shortages of Mental Health Care Professionals in U.S. Jails and Prisons in the Journal of Correctional Health Care.

Hour 3 of The Autism Network Podcastathon Dr. Doreen Granpeesheh shares essential information about anxiety, particularly as it relates to autism.  Viewer questions are encouraged. Autism expert Dr. Doreen Granpeesheh gives the definitive talk about anxiety as it relates to autism.  Anxiety has a great deal to do with a person's ability to cope, learn, and grow.  Masking the anxiety is not always the answer.  Listen as Dr. Doreen talks about successful ways to treat, and overcome the debilitating side of anxiety, so we can productively get back to learning and living. Dr. Doreen Granpeesheh Dr. Doreen Granpeesheh has dedicated over forty years to helping individuals with autism lead healthy, productive lives. She is licensed as a psychologist in California, Texas, Virginia, Oregon, Colorado, Michigan and Arizona and holds a Certificate of Professional Qualification in Psychology from the Association of State and Provincial Psychology Boards. She is a doctoral level Board Certified Behavior Analyst and is licensed as a behavior analyst in Arizona, New York, Nevada, Louisiana and Virginia. Dr. Granpeesheh began her studies in autism as an undergraduate at UCLA earning a bachelor's degree in 1984, and a Master's degree in psychology in 1987, followed by a Ph.D. in psychology from UCLA in 1990. While completing her degrees, Dr. Granpeesheh worked with Dr. Ivar Lovaas on the groundbreaking outcome study published in 1987 which showed a recovery rate of close to 50% among the study's research participants. Dr. Granpeesheh built on Dr. Lovaas's work, developing the CARD Model, which is a comprehensive, evidence-based approach to treating autism. In 1990, Dr. Granpeesheh founded the Center for Autism and Related Disorders, also known as CARD.  Under Dr. Granpeesheh's 30 years of leadership, CARD became one of the world's largest providers of ABA-based treatment for individuals diagnosed with autism spectrum disorder. With over 260 locations throughout the United States and internationally, CARD employed over 6,000 highly skilled professionals, and was a leading employer of Board Certified Behavior Analysts (BCBAs) providing behavioral treatment to thousands of families worldwide. CARD's highly regarded behavior management and skill acquisition programs were the culmination of decades of research in the field of autism treatment. As part of the nation's third largest non-governmental organization contributing to autism research, CARD researchers published groundbreaking studies that contributed significantly to the field of autism treatment research. In 2011, Dr. Granpeesheh founded Autism Research Group, a nonprofit organization whose mission was to identify and conduct treatment research that improves the quality of life for individuals with autism spectrum disorder. To increase access to evidence-based treatment, Dr. Granpeesheh founded Skills™, an innovative web-based platform that optimizes treatment programs for individuals with autism spectrum disorder.  Skills™ provides comprehensive assessment and curriculum, positive support planning for challenging behavior, progress tracking, and treatment evaluation.  and enables healthcare professionals, teachers, parents, and/or caregivers to design and manage comprehensive, individualized treatment programs for children and adolescents with autism spectrum disorder as well as tracking progress in real time by collecting and uploading data electronically. From 1990 to 2019, as CARD's CEO and chief clinician, Dr. Granpeesheh developed extensive state-of-the-art training programs for CARD's clinical employees, parents and caregivers, and school personnel.  As demand for CARD training programs increased, Dr. Granpeesheh established the Institute for Behavioral Training which provides web-based and in-person training programs targeting the specific training needs of school districts, parents and caregivers, physicians, and autism treatment providers. Dr. Granpeesheh has been a member of numerous scientific and advisory boards including the US Autism and Asperger's Association, The Autism File Journal, Autism 360-Medigenesis, the 4-A Healing Foundation and the Defeat Autism Now coalition.  In addition, Dr. Granpeesheh has served on the National Board of Directors of the Autism Society of America (ASA), the practice board of The Association for Behavior Analysis International (ABAI) as well as the Autism Human Rights and Discrimination Initiative Steering Committee, the Early Intervention Taskforce of the Senate Select Committee on Autism and Related Disorders and the Oversight Committee of the Department of Developmental Disabilities. In 2008, Dr. Granpeesheh produced and co-directed the documentary “Recovered: Journeys through the Autism Spectrum and Back”, a film about 4 children diagnosed with Autism who, after three years of intensive intervention, recovered and now lead productive and healthy lives. This documentary received significant recognition including “Best Documentary” in the Director's Chair Film Festival, official selection in the Victoria Independent Film Festival and special recognition in the ReelHeART International Film Festival of Toronto. As one of the foremost experts in autism diagnosis and treatment, Dr. Granpeesheh has appeared on numerous TV shows including Dr. Phil, the Doctors, Fox and Friends and other notable news segments to shed light on and answer questions regarding autism. In August 2009, her research entitled “Retrospective Analysis of Clinical Records in 38 Cases of Recovery from Autism” was published in the Annals of Clinical Psychiatry, showing that recovery from autism is possible with early, intensive intervention using ABA. This study echoed the results of Dr. Lovaas's earlier study and garnered Dr. Granpeesheh the prestigious George Winokur Clinical Research Award. In 2014, Dr. Granpeesheh co-authored the book Evidence-Based Treatment for Children with Autism, a comprehensive description of the model of treatment she developed over her 30 years of leadership at CARD. She has also authored over 50 peer reviewed publications on subjects concerning the diagnosis and treatment of Autism. In 2015, Dr. Granpeesheh co-authored a series of 4 articles that were published in the prestigious journal Pediatrics. These articles were the culmination of work from several think tanks concerning the early diagnosis and treatment of autism and continue to define the guiding principles of therapeutic process for medical and psychological professionals today. Dr. Granpeesheh is co-founder of The Autism Media Network which hosts “Autism Live”, the number one video podcast in the field of autism education. Since 2012, Dr. Granpeesheh has broadcast the “Dr. Doreen Show” on Autism Live, a weekly interactive web show providing support, resources, information, facts, entertainment, and inspiration to parents, teachers, and practitioners who work with individuals on the autism spectrum. Through the Ask Dr. Doreen Show, hundreds of families have been able to call in or write in and gain immediate guidance on various issues pertaining to their children. In 2022, Autism Media Network launched “Stories from the Spectrum” the first show to be entirely produced, directed by and featuring individuals on the spectrum of autism. In 2020, Dr. Granpeesheh retired as CEO of CARD and continues to contribute to the autism community as founding member and president of Autism Care Today (ACT), a nonprofit organization that she co-founded in 2005. ACT builds awareness and provides grant funding to families struggling with autism.  In addition, Dr. Granpeesheh remains a member of the Finance Committee of The Association for Behavior Analysis International, sits on the board of advisors of the Board of Psychology of UCLA, and is a member of the Board of Directors of the Behavioral Health Center of Excellence. In 2020, the Society for the Advancement of Behavior Analysis honored her by establishing the “Doreen Granpeesheh Fund for the Interdisciplinary Approach to the Treatment of Autism”, whose objective is to support educational pursuits that complement the behavioral treatment of autism with knowledge and expertise from related fields and with consideration of the individual as a whole. Dr. Granpeesheh remains committed to improving treatment efficacy by expanding the knowledge of behavior analysts to include a broad understanding of the diagnostic criteria, dietary protocols, and biomedical interventions currently in use for the treatment of autism. Awards and Accolades: 2007: The Autism Society of America's Wendy F. Miller Professional of the Year Award 2009: American Academy of Clinical Psychiatrists: George Winokur Clinical Research Award 2009: Autism Around the World: Appreciation Award 2010: Recognition by Mayor of Los Angeles, Antonio Villaraigosa for 20 years of commitment and dedication to the treatment of autism. 2010: Recognition and gratitude by Governor of California, Arnold Schwarzenegger for provision of support and treatment for those affected by autism in California. 2010: Autism Around the World: Appreciation Award 2011: Universal Love Foundation's Parent of Distinction Award 2012: Recognition from The Senate of the State of California Taskforce on Equity and Diversity, for exemplary leadership and inspiring contributions in promoting equality for all individuals who are overcoming the challenges of autism spectrum disorders. 2013: National Association of Professional Women for Outstanding Excellence and Dedication to Her Profession and the Achievement of Women 2014: Parenting Arizona: Raising the Bar Award 2015: The San Fernando Valley Business Journal's Women in Business Lifetime Achievement Award 2015: The NW Autism Foundation Champion of Autism Award 2015: Innovations in Healthcare Abby Award Finalist 2017: CODiE Best Solutions for Special Needs Students Award 2019: Autism Care Today's Denim Diamond and Stars Visionary Award 2021: Society for the Advancement of Behavior Analysis: Award for Enduring Programmatic Contributions to the Field. Resources: https://www.autismnetwork.com/category/ask-dr-doreen/ https://www.tiktok.com/@askdrdoreen https://www.instagram.com/askdrdoreen/

In this episode, the hosts dive into the science of smell & the odiferous side of the occult Why is incense such a popular offering? Does an oil's odour reflect its properties? And what on earth does a saint smell like?! This episode features four case studies across different traditions to explore the seemingly-ubiquitous - but surprisingly diverse - role of fragrance in the occult. You can also expect to hear about science of smell & how odour can interplay with cognition. smell ya later x REFERENCES - Brief summary: the science of smell! // Sell, C. S. (2006). On the unpredictability of odor. Angewandte Chemie International Edition, 45(38), 6254-6261. - Amazing book on the chemistry behind perfumery // Pybus, D. H., & Sell, C. S. (Eds.). (1999). The chemistry of fragrances (Vol. 17). Royal Society of Chemistry. - Olfaction and memory - how odour interplays with PTSD & emotion // Vermetten, E., & Bremner, J. D. (2003). Olfaction as a traumatic reminder in posttraumatic stress disorder: case reports and review. Journal of Clinical Psychiatry, 64(2), 202-207. && Zald, D. H., & Pardo, J. V. (1997). && Emotion, olfaction, and the human amygdala: amygdala activation during aversive olfactory stimulation. Proceedings of the National Academy of Sciences, 94(8), 4119-4124. - Tapputi, one of the world's first chemists (and perfume makers)! // https://arkeonews.net/the-3200-year-old-perfume-of-tapputi-the-first-female-perfumer-in-history-came-to-life-again/ - Odour in antiquity // https://ore.exeter.ac.uk/repository/bitstream/handle/10871/17556/GrantG.pdf - The role of scents in traditional Chinese religion // Habkirk, S., & Chang, H. (2017). Scents, community, and incense in traditional Chinese religion. Material Religion, 13(2), 156-174. - Osmogenesia & sensing the saints Saucier, C. (2010). // The sweet sound of sanctity: sensing St Lambert. The Senses and Society, 5(1), 10-27. && Harvey, S. A. (1998). St Ephrem on the scent of salvation. The journal of theological studies, 49(1), 109-128. - Amusing paper on 'oilers' with a lot in there about MLMs // Kieffer, K. G. (2021). Smelling Things: Essential Oils and Essentialism in Contemporary American Spirituality. Religion and American Culture, 31(3), 297-331.

Welcome to PsychEd — the psychiatry podcast for medical learners, by medical learners. This episode covers the “big picture” relationship between violence and severe mental illnesses such as schizophrenia and bipolar spectrum disorders. Our guest experts in this episode are Dr. Robert McMaster, Assistant Professor of Forensic Psychiatry at the University of Toronto and Dr. Ragy R. Girgis, Associate Professor of Clinical Psychiatry at Columbia University in New York. This episode is a good companion to Episode 15: Managing Aggression and Agitation with Dr. Jodi Lofchy, which covers how to identify and manage acute risk of violence in a clinical setting. The learning objectives for this episode are as follows: By the end of this episode, you should be able to… Describe the epidemiology of violence in severe mental illness (rates of perpetration vs. victimization, risk factors, quality of evidence)  Understand and critique how society currently addresses violence in those with severe mental illness  Discuss this topic with patients, caregivers and the public, and address common myths  Guests:  Dr. Robert McMaster - Assistant Professor of Forensic Psychiatry at the University of Toronto Dr. Ragy R. Girgis - Associate Professor of Clinical Psychiatry at Columbia University in New York Hosts: Dr. Alex Raben (Staff Psychiatrist), Dr. Gaurav Sharma (PGY4), Sena Gok(IMG), Josh Benchaya (CC4) Audio editing by: Gaurav Sharma Show notes by: Josh Benchaya, Gaurav Sharma, Sena Gok   Interview Content:   Learning Objectives: 02:29 Perceptions of Violence and Mental Illness: 03:53 Mental illness & Violence Link Evidence: 06:48 Violence Perpetration & Victimisation: 10:10 Risk of Violence Assessment (HCR 20 Model): 17:00 Mass Shootings & Mental Illness & Predictions: 20:30 Violence Risk Prediction: 25:25 Severe Mental Illness & Violence Risk Treatments: 29:40 Society's approach to Severe Mental Illness & Violence Misperceptions: 38:30 Mental Illness and Violence Stigma: 45:03 Case Vignette & Approach: 46:44 Summary of the episode: 58:00   References:   de Mooij, L.D., Kikkert, M., Lommerse, N.M., Peen, J., Meijwaard, S.C., Theunissen, J., Duurkoop, P.W., Goudriaan, A.E., Van, H.L., Beekman, A.T. and Dekker, J.J., 2015. Victimization in adults with severe mental illness: prevalence and risk factors. The British Journal of Psychiatry, 207(6), pp.515-522. Desmarais, S. L., Van Dorn, R. A., Johnson, K. L., Grimm, K. J., Douglas, K. S., & Swartz, M. S. (2014). Community violence perpetration and victimization among adults with mental illnesses. American journal of public health, 104(12), 2342-2349. Metzl, J.M., Piemonte, J. and McKay, T., 2021. Mental illness, mass shootings, and the future of psychiatric research into American gun violence. Harvard review of psychiatry, 29(1), p.81.   Buchanan, A., Sint, K., Swanson, J. and Rosenheck, R., 2019. Correlates of future violence in people being treated for schizophrenia. American Journal of Psychiatry, 176(9), pp.694-701.   Rund, B.R., 2018. A review of factors associated with severe violence in schizophrenia. Nordic journal of psychiatry, 72(8), pp.561-571.   Markowitz FE. Mental illness, crime, and violence: Risk, context, and social control. Aggress Violent Behav. 2011 Jan 1;16(1):36–44.   Pescosolido BA, Manago B, Monahan J. Evolving Public Views On The Likelihood Of Violence From People With Mental Illness: Stigma And Its Consequences. Health Aff Proj Hope. 2019 Oct;38(10):1735–43.   Ross AM, Morgan AJ, Jorm AF, Reavley NJ. A systematic review of the impact of media reports of severe mental illness on stigma and discrimination, and interventions that aim to mitigate any adverse impact. Soc Psychiatry Psychiatr Epidemiol. 2019 Jan 1;54(1):11–31.   Srivastava K, Chaudhury S, Bhat PS, Mujawar S. Media and mental health. Ind Psychiatry J. 2018;27(1):1–5.   Stuart H. Media portrayal of mental illness and its treatments: what effect does it have on people with mental illness? CNS Drugs. 2006;20(2):99–106.   Rowaert S, Vandevelde S, Lemmens G, Audenaert K. How family members of mentally ill offenders experience the internment measure and (forensic) psychiatric treatment in Belgium: A qualitative study. Int J Law Psychiatry. 2017;54:76–82.   Bjørn Rishovd Rund (2018) A review of factors associated with severe violence in schizophrenia, Nordic Journal of Psychiatry, 72:8, 561-571, DOI: 10.1080/08039488.2018.1497199  References cited by our experts:   Steadman, H.J., Monahan, J., Pinals, D.A., Vesselinov, R. and Robbins, P.C., 2015. Gun violence and victimization of strangers by persons with a mental illness: data from the MacArthur Violence Risk Assessment Study. Psychiatric services, 66(11), pp.1238-1241. [00:05:26]   Appelbaum PS, Robbins PC, Monahan J. Violence and delusions: data from the MacArthur Violence Risk Assessment Study. Am J Psychiatry. 2000 Apr;157(4):566-72. doi: 10.1176/appi.ajp.157.4.566. PMID: 10739415. [00:05:26]   Torrey EF, Stanley J, Monahan J, Steadman HJ; MacArthur Study Group. The MacArthur Violence Risk Assessment Study revisited: two views ten years after its initial publication. Psychiatr Serv. 2008 Feb;59(2):147-52. doi: 10.1176/ps.2008.59.2.147. PMID: 18245156. [00:05:26]   Witt, K., Hawton, K. and Fazel, S., 2014. The relationship between suicide and violence in schizophrenia: analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset. Schizophrenia research, 154(1-3), pp.61-67. [00:08:46] Sariaslan, A., Arseneault, L., Larsson, H., Lichtenstein, P., & Fazel, S. (2020). Risk of subjection to violence and perpetration of violence in persons with psychiatric disorders in Sweden. JAMA psychiatry, 77(4), 359-367. [00:11:20] Douglas, K. S., Shaffer, C., Blanchard, A. J. E., Guy, L. S., Reeves, K., & Weir, J. (2014). HCR-20 violence risk assessment scheme: Overview and annotated bibliography. HCR-20 Violence Risk Assessment White Paper Series, #1. Burnaby, Canada: Mental Health, Law, and Policy Institute, Simon Fraser University. [00:18:53] Girgis, R.R., Rogers, R.T., Hesson, H., Lieberman, J.A., Appelbaum, P.S. and Brucato, G., 2022. Mass murders involving firearms and other methods in school, college, and university settings: findings from the Columbia Mass Murder Database. Journal of forensic sciences. [00:25:11]       CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association. For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.  

I enjoyed having the opportunity today to "pick the brain" of Dr. Martin Hsia, a  Clinical Psychologist and expert in Obsessive-Compulsive Disorder (OCD). We talked in-depth about many forms of obsessive thoughts and compulsive behaviors commonly encountered with OCD. Dr. Hsia provides many examples of what differentiates "normal" thinking and behavior from OCD symptoms. Dr. Hsia is the Clinical Director at the Cognitive Behavior Therapy Center of Southern California (http://www.CBTSoCal.com). CBT SoCal is a group practice that specializes in treating people with Anxiety Disorders, most specifically Obsessive-Compulsive Disorder in its various forms, as well as CBT for unique presentations such as Trichotillomania, Excoriation Disorder, Body Dysmorphic Disorder, Insomnia, Tics, and Chronic Pain. Dr. Hsia is a member of the International OCD Foundation, a Diplomate with the Academy of Cognitive Therapy, and has lectured and supervised as Adjunct Professor of Clinical Psychiatry and Behavioral Sciences at USC Keck School of Medicine.

We take a look at vaping and the health risks that surround it with Dr. Mashal Khan,  Assistant Professor of Clinical Psychiatry at Weill Cornell Medicine and part of the Addiction Psychiatry Team at New York-Presbyterian Hospital. We also cover: (3:28) smoking and vaping trends for teens and young adults, (4:56) the rise of e-cigarettes, (7:33) nicotine and its impact on your body, (14:30) building a tolerance to vaping, (16:52) effects of chronic nicotine use,(19:23) vaping and marijuana, and (23:00) steps to quitting. Learn more about Dr. Khan here: https://weillcornell.org/mashal-khan-md Resources to quit vaping: https://mylifemyquit.com/ https://teen.smokefree.gov/ https://truthinitiative.org/ https://www.thetruth.com/ https://www.nysmokefree.com/ 1-866-NY-QUITS

Dr. Elizabeth Ford was the former Director of Forensic Psychiatry at Bellevue Hospital and the Chief of Psychiatry at Rikers Island. Dr. Ford has spent the majority of her 20-year career working to improve treatment for incarcerated people with serious mental illness. She is currently the Director of Mental Health/Criminal Justice Initiatives and Associate Professor of Clinical Psychiatry at Columbia University. Eileen and Dr. Ford discuss mental illness treatment within the prison system, how jails function as the largest psych wards in the United States, and the work being done to improve care behind bars.   Show links:   Follow @eileen on Instagram   Follow @killerandasweetthang on Instagram   Follow @eileeninparis on TikTok    Follow @goingmentalpodcast on Instagram   More information at: Goingmental.com     Produced by Dear Media.

On this week's podcast, we have good news for women: you improve with age. Dr. Louann Brizendine's new book The Upgrade details how the female brain improves in the time of life typically known as menopause. We delve into how hormonal changes can actually help our productivity and why you can look forward to your 30s, 40s, 50s, 60s, and beyond. That's right, ladies: your best days are ahead. Dr. Louann Brizendine is a neuropsychiatrist and author of the new book The Upgrade: How the Female Brain Gets Stronger and Better in Midlife and Beyond. She's the Lynne and Marc Benioff Endowed Chair in Clinical Psychiatry at the University of California, San Francisco; founder of UCSF's Women's Mood and Hormone Clinic; and bestselling author of The Female Brain and The Male Brain.--She Thinks is a podcast for women (and men) who are sick of the spin in today's news cycle and are seeking the truth. Once a week, every week, She Thinks host Beverly Hallberg is joined by guests who cut through the clutter and bring you the facts. You don't have to keep up with policy and politics to understand how issues will impact you and the people you care about most. You just have to keep up with us. We make sure you have the information you need to come to your own conclusions. Because, let's face it, you're in control of your own life and can think for yourself. You can listen to the latest She Thinks episode(s) here or wherever you get your podcasts. Then subscribe, rate, and share with your friends. If you are already caught up and want more, join our online community. Be sure to subscribe to our emails to ensure you're equipped with the facts on the issues you care about most: https://iwf.org/connect. Independent Women's Forum (IWF) believes all issues are women's issues. IWF promotes policies that aren't just well-intended, but actually enhance people's freedoms, opportunities, and choices. IWF doesn't just talk about problems. We identify solutions and take them straight to the playmakers and policy creators. And, as a 501(c)3, IWF educates the public about the most important topics of the day. Check out the Independent Women's Forum website for more information on how policies impact you, your loved ones, and your community: www.iwf.org. Subscribe to IWF's YouTube channel. Follow IWF on social media: - on Twitter- on Facebook- on Instagram#IWF #SheThinks #AllIssuesAreWomensIssues See acast.com/privacy for privacy and opt-out information.

Welcome to Difficult Conversations with Dr. Anthony Orsini.   In previous episodes, we've had some guests that talked about the problem of substance abuse among physicians. We heard about an incredible film documentary on physician suicide and we heard from  physicians about their journey with burnout,  This is an important topic because it doesn't just impact doctors and their families, it also affects patients. According to one statistic, physician suicide affects 900,000 patients per year in the United States, and a physician dies by suicide in the U.S. on an average of one per day,  That speaks to a very larger problem in healthcare.  Recently, I read the book, Why Physicians Die by Suicide:  and I knew I had to have the author on since he has a unique insight into this problem. Today, my guest is Dr. Michael Myers, Professor of Clinical Psychiatry at SUNY-Downstate Health Sciences University in Brooklyn.  He's a specialist in physician health , a researcher, teacher, and consultant, as well as an author of nine books. He's a highly regarded speaker and lecturer on all aspects of physician well-being. Michael shares the story about his medical school roommate who committed suicide.  We find out how Dr. Myers started out in Internal Medicine and the game changing decision that made him take the leap into Psychiatry. Dr. Orsini and Dr. Meyers share their concerns on the “elephant in the room” problem, how we got into this crisis, . Many physicians are asking for help, but as Dr. Meyers explains there is work being done to make it easier and more permissible to ask for help. We dive into Dr. Meyers book, and he shares stories about the hundreds of families he interviewed, and how this changed his life,  To the family and friends of physicians out there, Dr. Meyers goes in depth on how they can identify the red flags  To the physicians  who are feeling depressed or having suicidal thoughts, he sheds some light on what the rules and laws are that protect them, and the best way to find the psychiatrist that is right for them.    If you enjoyed this podcast, please hit subscribe on your favorite podcast platform. Go ahead and download this episode now! Host:Dr. Anthony OrsiniGuest:Dr. Michael MyersFor More Information:Difficult Conversations PodcastThe Orsini WayThe Orsini Way-FacebookThe Orsini Way-LinkedInThe Orsini Way-InstagramThe Orsini Way-Twitterdrorsini@theorsiniway.comIt's All In The Delivery: Improving Healthcare Starting With A Single Conversation by Dr. Anthony OrsiniResources Mentioned:Michael F. Myers, MD WebsiteDr. Michael Myers LinkedInDr. Michael Myers TwitterWhy Physicians Die by Suicide: Lessons Learned from Their Families and Others Who Cared by Michael F. Myers, MD